1. Introduction {#S1}
===============

Burns are generally defined as skin wounds caused by thermal/heat exposure (e.g. fire, hot liquids, solids or gases), electricity, chemical materials (e.g. strong bases or strong acids), radiation exposure (e.g. ultraviolet light, ionizing radiations such as X-ray, microwaves, etc.), and so forth. The ultimate therapeutic goal is to prevent and treat infection, while encouraging satisfactory healing that preserves function \[[@R1]\]. In accordance with the latest report from the World Health Organization, about 265,000 deaths occur due to thermal burn wounds each year; these fatalities are especially common in low-to-middle-income countries, and particularly in the South-East Asia Region \[[@R2]\]. In India alone, over 1,000,000 people are inflicted with moderate or severe burns every year. More than 88% of these burns are caused by flames or contact with hot or boiling liquids. Patients with severe burns over a significant proportion of the body surface have received a potentially devastating injury, and need immediate skillful emergency care to minimize mortality, and will often require long-term rehabilitation and recovery to prevent the occurrence of crippling scars and other morbidity. The skin surface has a pivotal role in the maintenance of body fluid homeostasis, thermoregulation, serves as a barrier against the outside world (in particular excluding pathogenic microorganisms), and regulates many metabolic processes \[[@R3]\]. The skin is also the body's largest and most active immune organ \[[@R4]\]. Thermal injury is a complex process that needs advanced methods to prevent burn infection, and the application of effective antimicrobial therapy if infection has taken place (as it most often does), together with strategies to stimulate wound healing and prevent scarring. Initially burned patients should be provided with fluid resuscitation, pulmonary care, nutritional support, as well as antimicrobial control as emergency measures \[[@R5]\]. The survival of thermally burned victims may critically depend on exactly what is done, particularly to the burn sites themselves \[[@R6]\]. Remarkable advances have been obtained in wound dressing platforms, advent of new antimicrobial agents, and recommendations have been made for early full thickness burn excision and grafting. Nevertheless studies still are ongoing to improve the wound healing process and its effectiveness. Most efforts have been conducted to boost the antimicrobial activity of a broad range of topically applied therapeutic agents, facilitating disinfection in wound sites, as well as improving wound healing processes and tissue regeneration mechanisms \[[@R7], [@R8]\]. Some conventional treatments are based on application of topical antimicrobial substances such as combinations of topical antibiotics, povidone-iodine, silver-sulfadiazine, chlorhexidine, mafenide acetate and such like. Newer avenues that are being explored are immune-based antimicrobial molecules (polypeptides like defensins) and therapeutic microorganisms (probiotics and bacteriophages). In addition, remarkable results have recently been reported for a range of light therapies using NIR, visible light (blue or green); ultraviolet light, and the combination of light with photosensitizing dyes \[[@R9]\]. Moreover, some other innovative approaches such as stem and other types of cell therapy have led to significantly improved wound healing. In recent years, despite the noticeable progress, the relatively new areas of nanomedicine and nanotechnology in general, have been strongly pressed into service against burn infections. In this regard, nanostructures (NSs) have been developed as advanced delivery vehicles for: cell therapies, growth factors, gene therapy vectors, advanced antimicrobial agents, and agents that will stimulate wound healing. Moreover, a whole new arsenal of smart stimulus-responsive delivery vehicles and nano-robots have emerged using nanostructured platforms e.g. films, 3D-scaffolds, nanoparticles (NPs) (activated by e.g. light, enzymes, pH, ultrasound, etc.), photoactivated NS-based approaches. The most-often utilized NSs platforms for wound healing and burn reconstruction can be categorized into nanofibers, NPs, films and 3D-scaffolds. [Figure 1](#F1){ref-type="fig"} schematically illustrates several important conventional, developing or innovative approaches for wound healing and burn infection inhibition, which have all been under investigation in recent years.

Animal models are critically important for laboratory investigations into burn wound healing, as in vitro studies can only go so far, and there is a reluctance to test nanotechnology-based products directly on human burn victims. These models will allow better understanding of wound-associated processes and mechanisms, which then can lead to substantial advancements in burn injury therapies.

2. Skin structure and the burn wound healing process {#S2}
====================================================

An understanding of normal skin physiology, pathogenesis of burns, as well as appreciation of infections that develop in burns (with different classes of microorgansism arriving at different stages of burn development) are all important for understanding the role of nanotechnology in burn wounds.

Generally, the skin is composed of three distinct layers ([Figure 2-a](#F2){ref-type="fig"}) including the epidermis, dermis and hypodermis \[[@R10]\]. The epidermis prevents the entry of virulent microorganisms, as maintaining body hydration. The five layers (called stratums) consisting of: basale, spinosum, granulosum, lucidum, and corneum form the epidermis layers of skin, respectively. \[[@R11]\]. These layers are made from diverse immune and non-immune cell types such as keratinocytes, melanocytes, merkel cells, langerhans cells, CD8+ T cells, corneocytes and stem cells \[[@R11]--[@R13]\]. The basal layer is the proliferative portion of the epidermis producing keratinocytes that can go on to differentiate into the spinous layer, granular layer as well as outermost stratum corneum layers. The skin of the palms and soles has an additional stratum lucidum or clear layer. Stem cells residing in the basal epidermis are responsible for continually replacing keratinocytes that are normally lost by exfoliation, as well as for regenerating wounded skin \[[@R14]\]. The dermis layer is a layer between the hypodermis and epidermis, which is largely made of collagen protein, blood vessels (arterioles, venules, capillaries) sweat glands, hair roots, nerve cells, lymphatic vessels and mesenchymal stem cells (MSCs) \[[@R15]\]. The primary function of the dermis is to provide structural toughness to the skin. The differentiation of dermal MSCs cultured in the laboratoryinto chondrocytes,, osteocytes, adipocytes,, smooth muscle cells, hematopoietic cells, neurons and glia have been reported \[[@R16]\]. The hypodermis or subcutaneous fat, is comprised of adipocytes, macrophages, vasculature, nerves and fibroblasts, and its function is to support and anchor the dermal and epidermal layers \[[@R17]\]. [Figure 2](#F2){ref-type="fig"} schematically illustrates the structure of skin ([Figure 2-a](#F2){ref-type="fig"}), and its different constituent layers and cells ([Figure 2-b](#F2){ref-type="fig"}).

Classification of the severity of burn injuries usually is evaluated using two criteria; assessment of the depth of the thermal damage, and an estimation of percentage of total body surface area (TBSA) affected by a burn injury. In the first method burn wounds are classified into four degrees ([Figure 2-a](#F2){ref-type="fig"}). First degree burns that involve only the epidermis display redness, pain at the site of damage, and dryness. Second degree burns can affect either papillary layer (i.e. the upper dermis) or reticular layer (i.e. the deeper dermis) with a white or yellow color, blistering of the skin, and a moist appearance. In third-degree burns, there is full thickness destruction of both epidermis and dermis, and a stiff or leathery consistency. Scarring and contractures will develop after healing. Fourth-degree burns cause catastrophic damage in underlying tissues, muscle, tendons, ligaments and even bone \[[@R18]\]. As mentioned, burns are also assessed in terms of percentage of TBSA. The rule of nines in the affected area is a quick way to estimate the percent TBSA affected ([Figure 3](#F3){ref-type="fig"}) \[[@R3], [@R5], [@R19]\]. More precise assessment can be evaluated by Lund & Browder charts where diverse proportions of body parts in children and adults are accounted for; e.g. burn wounds greater than 10% in children, have the same severity as 15% for adults. This is important because hypovolemic shock can be potentially life threatening. When about 25% of the body area is affected by burns, loss of fluid from the damaged microvessels produces edema and hypoproteinemia. The volume of fluid replacement with isotonic crystalloid solution (Ringer's lactate) can be calculated by the Parkland formula: V(mL) = 4 × body weight(kg) × %TBSA \[[@R7], [@R20]\].

The final goal in burn injury healing is the rapid replacement of normal skin with minimal scarring. The healing of burn damage is a biological process including four overlapping phases ([Table 1](#T1){ref-type="table"}), homeostasis phase, inflammatory phase, proliferation phase and remodeling phase \[[@R21]\].

2.1 Homeostasis phase {#S3}
---------------------

About 10-min after the thermal insult occurs, the initial phase commences as an autonomic response to attempt to minimize the damage. In this phase, several phenomena occur including platelet aggregation, immune activation, blood clotting and complement system activation. Here, the blood clot encompasses vitronectin, fibronectin, fibrin and thrombospondins, which supply a scaffold-like matrix for the migration of fibroblasts leukocytes, keratinocytes and endothelial cells as well as causing the accumulation of growth factors \[[@R15]\].

2.2 Inflammatory phase {#S4}
----------------------

This occurs 1--3 days after the infliction of the burn wound. This phase can be divided into the early phase with neutrophils arriving in the first days and a late phase; 3 days after the initiation of damage, when monocytes transform into macrophages. Neutrophils produce tumor necrosis factor (TNF-α), interleukin-1 (IL-1) and (IL-6) that activate the inflammatory response and stimulate vascular endothelial growth factor (VEGF) and IL-8 secretion to repair blood vessels, and macrophages produce transforming growth factors (TGF-α, and TGF-β), fibroblast growth factor (FGF), platelet-derived growth factor (PDGF) and VEGF, to stimulate cell expansion and migration and the extracellular matrix (ECM) generation molecules by resident cells of the skin. Adaptive immunity takes at least 4 days after the damage initiation involving lymphocytes (T-cells and B-cells) \[[@R22], [@R23]\].

2.3 Proliferation phase {#S5}
-----------------------

Following the inflammatory response, a coordinated proliferation phase occurs, which includes three steps; re-epithelialization, angiogenesis and formation of granulation tissue. The proliferation phase occurs 3--10 days after the initiation of injury. Re-epithelialization is induced by activation of cytokines and growth factors including insulin-like growth factors (IGF-1), nerve growth factor (NGF), epidermal growth factor (EGF), and keratinocyte growth factor (KGF), which cause expansion of keratinocytes, epithelial cells, stem cells and fibroblasts. Keratinocytes, fibroblasts and fibroblast-derived macrophages immigrate into the wound and expand during the regeneration of the burn-damaged tissue. Some fibroblasts differentiate into myofibroblasts; then the fibroblasts and myofibroblasts manufacture ECM, particularly collagen that produces the mature scar \[[@R15], [@R24]\]. In the proliferation phase, new blood vessels are created (angiogenesis). In this phase, several growth factors are involved such as VEGF, PDGF, FGF-β, granulocyte-macrophage colony-stimulating factor (GM-CSF) and thrombin, which are the foremost activating molecules for endothelial cell growth. The proteolytic enzymes secreted by the activated endothelial cells secrete dissolve the basal lamina and create an environment in which they can proliferate and immigrate into the wound \[[@R15], [@R25]\]. The final step of the proliferation phase is the production of granulation tissue, which can be specified by the presence of many fibroblasts, granulocytes and macrophages. The main cells in the granulation phase are fibroblasts that produce collagen and other ECM molecules. The ECM supplies an appropriate scaffold for cell adhesion, and organizes the growth and differentiation of the cells including fibroblasts. At the end of this phase, the differentiation of the fibroblasts into myofibroblasts occurs (forming a scar) or else undergo apoptosis \[[@R26], [@R27]\].

2.4 Remodeling phase {#S6}
--------------------

This final step of wound healing is called the remodeling phase. During this step, wound remodeling initiates 2--3 weeks after the burn damage, and continues for as long as a year or more; here the wound scar produces more collagen and elastin, and also fibroblasts mature into myofibroblasts. Beside fibroblast transformation, death of keratinocytes and inflammatory cells (such as T cells and macrophages) play a vital role in the ending of the response to the injury \[[@R15], [@R28]\].

Topical methods have been conventionally used as treatments for burns. Many of these are traditional disinfectants and antiseptics such as povidone-iodine, chlorhexidine, combinations of topical antibiotics, silver-sulfadiazine, and mafenide acetate. In the following sections, we will cover more innovative approaches such as immune-based antimicrobial molecules, nanotechnology based antimicrobial agents, therapeutic microorganisms, and antimicrobial phototherapy and ultrasound therapy, and stem cell-based treatments for therapy of burn infection and burn wound healing. Since many of these agents are intrinsically cytotoxic towards bacteria, fungi and other microorganisms, a clear concern that must be addressed is whether they will damage host cells in the burn site, or maybe adversely affect wound healing [Table 2](#T2){ref-type="table"}.

3. Biological-based approaches for burn wound healing {#S7}
=====================================================

Some conventional treatments are based on application of topical antimicrobial substances such as combinations of topical antibiotics, povidone-iodine, silver-sulfadiazine, chlorhexidine, mafenide acetate and such like. Newer avenues that are being explored are immune-based antimicrobial molecules (polypeptides like defensins) and therapeutic microorganisms (probiotics and bacteriophages).

3.1 Immune-based antimicrobial molecules {#S8}
----------------------------------------

### 3.1.1 Antimicrobial peptides (AMPs) {#S9}

AMPs are naturally or synthetically generated cationic polypeptide molecules, which include some specific amino acids that produce an overall amphipathic conformation \[[@R29], [@R30]\]. These molecules can be naturally produced by many different organisms including bacteria, amphibians, insects and mammals and an active research effort in screening and discovery is still underway. AMPs are also produced by a diverse range of cell types well found in the skin, mucosal surfaces and immune cells. Synthetic approaches are also available for generation of AMPs. AMPs as antimicrobial agents are able to destroy an wide range of microorganisms. Their antimicrobial mechanism of action operates via attaching to and disrupting the negatively charged microbial cell membrane as well as suppressing the generation of important molecules of microorganisms consisting of proteins and nucleic acids, thus inhibiting the microorganism growth. Hence, they can be applied for the treatment of burn infections \[[@R29], [@R31]--[@R33]\].

Various natural AMPs such as indolicidin and ranalexin have been introduced as potential antimicrobial agents to treat infectious diseases \[[@R34], [@R35]\]. Cathelicidins (a member of the AMP family) are found in lysosomes of macrophages, polymorphonuclear leukocytes (PMNs), and keratinocytes. They are pivotal molecules for immune responses to microbial infections. They have broad-spectrum antimicrobial effects against fungi, viruses, and Gram-positive and Gram-negative bacteria. These small peptides kill virulent pathogens by destroying their cell membrane, and can neutralize the biological activity of their endotoxins \[[@R36]\]. Moreover, they can adhere to membrane receptors of immune cells such as toll-like receptors (TLRs) on antigen-presenting cell including monocytes, macrophages, and dendritic cells, as well as non-immune cells such as epithelial cells and keratinocytes. Cathelicidins and their derivative peptides such as LL-37 can be used topically to treat burn wound infections \[[@R37], [@R38]\]. Lactoferrin is an AMP, and binds to iron in a similar manner to transferrin (serum carrier of iron). This peptide exists in neutrophil granules, milk, tears, saliva, sweat, nasal secretions, and the genital tract. It exerts antibacterial and antifungal activity through microbial membrane disruption as well as iron sequestration, thus repressing microorganism growth \[[@R39]--[@R41]\].

Synthetically-obtained AMPs have been also investigated for their enhanced antimicrobial activity. In an investigation Zhong et al. developed β-sheet SAMPs including IK8D, IK8L, and IK8-2D to inhibit multidrug-resistant *P. aeruginosa*, the most common Gram negative bacteria isolated from burn wound infections of humans. These SAMPs were applied for treatment of *P. aeruginosa*-infected burn wounds in mice. Findings revealed that among the SAMPs, IK8L could significantly inhibit *P. aeruginosa*, and its successive administration did not cause drug resistance \[[@R31]\]. Recently, Mohamed et al. evaluated the antibacterial activity of SAMPs for treatment of MRSA-induced infection, one of the most virulent microorganisms in human wounds. Herein, the antibacterial function of two topically applied SAMPs including WR12 (consisting of a 12 residue peptide of arginine and tryptophan) and D-IK8 (made of an 8 β-sheet peptide structure) against MRSA was evaluated. These SAMPs were found to inhibit MRSA in both stationary and intracellular bacterial growth phases compared to the control groups (i.e. linezolid and vancomycin) in vivo, as well eradication of *S. aureus* and *S. epidermidis* in vitro. The in-vivo evaluation indicated both the SAMPs regulated the immune system and decreased generation of pro-inflammatory cytokines e.g. TNF-α and IL-6 \[[@R42]\]. In another study, charge- and structure-manipulated SAMPs showed enhanced antimicrobial activity and immunomodulatory ability. Herein, a pendant aromatic group was added to the SAMP sequence to achieve an enhanced antibacterial activity against Gram negative bacteria e.g. *E. coli*. The SAMP with the addition of 6 charges and a naphthalene ring showed increased selectivity against both Gram negative- and Gram positive bacteria e.g. *E. coli* and *S. aureus*. The regulation of macrophage immunomodulatory function with and without a TLR agonist (i.e. lipopolysaccharide) as well as the generation of neutrophil chemoattractant activity were also demonstrated \[[@R43]\].

### 3.1.2 Passive immunotherapy {#S10}

This approach is based on humanized and chimerized forms of specific monoclonal antibodies (mAb) generated by engineering transgenic mice and cultured hybridoma cells. For example, antibodies against the *Pseudomonas aeruginosa* lipopolysaccharide O-side chain structure can be produced in transgenic mice. Other examples of passive immunotherapeutics are flagellin-binding antibodies that recognize; bacterial flagellins. These structures are essential virulence factors responsible for the rapid movement of bacteria and facilitate bacterial invasion into tissue. High titer of mAbs such as anti-flagellin mAb could be used as an effective molecular approach to diminish mortality and morbidity induced through burn wounds with *P. aeruginosa* infection \[[@R44]--[@R46]\]. Exopolysaccharide (EPS) of *P. aeruginosa* is biosynthesized by the polysaccharide synthesis locus (Psl) and includes galactose- and mannose-rich molecules. The *psl* gene cluster consists of 15 genes encoding proteins capable for EPS synthesis, which is considered to be an essential factor for bacterial biofilm formation \[[@R47]\]. Another approach uses antibodies that bind to *P. aeruginosa* V-antigen (PcrV). PcrV is involved in the type III toxins secretion system (TTSS) that allows toxins to be released from the cells. PcrV is a structural protein and hydrophilic translocator of TTSS, which has a pivotal role in bacterial injection into host cells in order to initiate an infection \[[@R48], [@R49]\]. PcrG is also a cytoplasmic regulator that can interact with the intramolecular coiled-coil region of PcrV protein and regulates TTSS \[[@R50]\]. Passive mAb treatment against PcrV, so-called PcrV immunization, enhances survival rate in murine burn models infected with *P. aeruginosa* \[[@R51], [@R52]\].

3.2 Reactive oxygen species and nitric oxide generators {#S11}
-------------------------------------------------------

Reactive oxygen species (ROS) as potent antimicrobial agents are defined as very reactive molecules containing oxygen including hydroxyl radicals(•OH), hydrogen peroxide (H~2~O~2~), superoxide (O~2~․−), and singlet oxygen(^1^O~2~), produced by oxygen reduction in inflammatory leukocytes particularly neutrophils at infectious damaged sites \[[@R53]\]. ROS produced by defending host cells are able to inhibit a diverse range of microorganisms. The activity of superoxide and hydrogen peroxide is less effective than both hydroxyl radical and single oxygen, because of their detoxification due to presence of endogenous anti-oxidants related to enzymatic and non-enzymatic mechanisms; while no enzyme can detoxify hydroxyl radical or single oxygen (although organic antioxidant molecules can quench them), so they are extra lethal for pathogenic microorganisms \[[@R54]\]. Unfortunately, ROS are able to interact with host biomolecules and cause cellular and finally tissue damage. Pathogens can inhibit ROS by their own enzymes with anti-oxidant activity such as catalase and superoxide dismutase.. ROS have bactericidal and virucidal effects that are utilized by human cells against microorganisms in burn wound infections \[[@R55], [@R56]\]. Nitric oxide (NO) is a reactive free radical with a short half-life. NO is made from L-arginine by the enzyme NO synthase both constitutively and induced pathways of human immune cells \[[@R57]\]. Its antimicrobial activity is caused by damage to microbial DNA, DNA repair enzymes and lipid damage to microorganisms. NO generation has been reported as one of the main processes occurring in wounds and during skin reconstruction. Many recently produced topical gels can deliver NO content for treatment of skin wounds. NO recruits hair follicle stem cells for the re-epithelialization of skin wounds. It also improves angiogenesis and accelerates collagen production in the damaged site. Therefore NO has been utilized for burn wound healing through several mechanisms \[[@R58], [@R59]\].

3.3 Antimicrobial agents {#S12}
------------------------

### 3.3.1 Metallic elements {#S13}

Several metallic elements have been tested as effective materials to treat microbial infections \[[@R60]\]. Silver compounds have been utilized in burn infection treatment. Ionized silver (Ag^+^) compounds can react with thiol moieties of enzymes and proteins in the microbial cells, thus inhibiting growth and metabolism of a wide range of microorganisms. Moreover, silver ions are able to bind to cell walls and intracellular vacuoles of bacteria, which inhibit microbial division. Silver also causes membrane damage and disrupts electrical conductivity and membrane potential \[[@R61]\]. Silver nitrate was the original agent used for burns, which is utilized to inhibit the growth of microorganisms. It is still utilized as a treatment for burns, but concerns about host toxicity have led to the development of other silver derivatives \[[@R62]\]. Silver sulfadiazine (SSD) is another derivative that can be applied to prevent against microbial wound dressing and cell proliferating uses on the skin damaged surface \[[@R63]\].

Bismuth-thiols are other metal compounds that have antibacterial activity against staphylococci causing wound damage \[[@R64]\]. Copper (Cu) as a metal element and its derivatives such as Cu-nicotinate complex have natural antimicrobial activity \[[@R65]\]. Cu ions bind to some vital groups of microorganisms and suppress their enzymes. It has been reported that Cu salts can be used on infected skin wounds such as burns \[[@R66]\]. Cu compounds have also been indicated to have antibacterial activity against *Vibrio cholerae, Shigella flexneri, Escherichia coli, Salmonella typhi* and *Salmonella paratyphi* \[[@R67]\]. Gallium (Ga) is a metallic element that is not found in its pure form in nature, while its ionic Ga^3+^ form has been found in many minerals such as those containing aluminum and zinc. Ga^3+^ compounds have been shown to have antimicrobial activity. Another metal element is ferric iron (Fe^3+^), which is a vital element that has a critical role in bacterial growth and metabolic pathways \[[@R68]\]. The antimicrobial activity of Ga^3+^ maltolate salts against *P. aeruginosa* infections in murine burn wounds, was shown to induce inactivation of Fe^3+^-dependent redox enzymes, which had important roles in cell proliferation of bacteria. The results showed substantial decreases in the colony forming units of *Acinetobacter baumannii* and *Staphylococcus aureus* in the wound site \[[@R69]\].

Halogen based compounds including: fluorine, chlorine, bromine and iodine, have been used as antimicrobials. Hypochlorous acid is a reactive chlorine compound that can damage DNA and inactivate oxidative phosphorylation enzymes in microorganisms. HClO has a potential virucidal effect and disturbs the nucleic acids and capsids of viruses, and can be also used for disinfection of contaminated burn wounds \[[@R70]\]. Iodine molecules suppress essential enzymes of microorganisms by attaching to the sulfur groups of their proteins \[[@R71]\]. Iodine has effective antimicrobial activity against fungi and spores. Iodophors are preparations that contain iodine in combination with a solubilizing agent that can release free iodine molecules in situ. Iodine compounds have been applied as antiseptics and surface disinfectants for treatment of burn wound infections \[[@R72], [@R73]\].

### 3.3.2 Biopolymeric agents {#S14}

Other naturally occurring antimicrobial compounds can also interact with microbial cells and induce membrane disruption. Chitin is the second most commonly-found biopolymer (behind cellulose) and is a linear polysaccharide isolated from crustacean shells, fungal cells and yeast. A common chitin derivative, chitosan, can be obtained by chemical extraction and hydrolysis of acetyl groups. The positively-charged structure of chitosan (CS) is the base for its therapeutic properties such as antimicrobial activity, fast blood coagulation and electrostatic immobilization of wound microorganisms \[[@R74], [@R75]\]. XF porphyrins such as XF-73 and XF-70 are dicationic porphyrin compounds, originally developed for photodynamic therapy \[[@R76]\]. However these agents were also found to disrupt the bacterial membrane in many bacterial species. XF-70 and XF-73 have been reported as potential suppressors against non-dividing or slow-growing forms of bacteria such as *S. aureus*. Additionally, these compounds have shown an effective inhibition activity against bacterial biofilms \[[@R77], [@R78]\]. Polyphenolic compounds such as tannins can be purified from several plant species such as tea, vegetables, cereals, beverages, grapes, apples, pears and cherries. Plants containing tannins have been used in medicine for their antimicrobial properties \[[@R79]\]. Essential oils such as Valencia orange oil and tea tree oil are substances extracted from various plants and used in cosmetics, cuisine and medicine \[[@R80]\]. Many researchers have reported specific oils display antimicrobial activity, applicable as a topical therapy against infections induced in burn wound \[[@R81]\]. Alginate is a derivative of *Laminaria digitata* brown seaweed \[[@R82]\]. Alginate-silver compounds and alginate oligomer-loaded with antibiotics have been utilized as antimicrobial agents against various virulence microorganisms such as *Enterococcus faecalis, Enterococcus faecium, P. aeruginosa, E. coli, and so forth* \[[@R83], [@R84]\]. Polyamines inhibit efflux pumps situated on microbial membranes that function to pump out antibiotics, and which are a major cause of microbial multi-drug resistance. Infections in burns induced by drug-resistant bacteria e.g. *S. aureus* have been reported to be treated using preparations containing polyamine compounds \[[@R85]\]. Aerobic (and anaerobic microorganisms) quickly colonize skin wounds after burn damage. Partly owing to the widespread application of antimicrobial compounds e.g. antibiotics, fungi and yeasts are observed to colonize burns particularly at later time points \[[@R86]\]. Mafenide acetate is a dose-depended bactericidal and bacteriostatic agent that can inhibit Gram-negative and Gram-positive bacteria. Mafenide acetate is widely applied in burn injury treatment \[[@R87], [@R88]\]. Firmocidin is a compound derived from the normal commensal bacterial species that lives on the skin, *Staphylococcus epidermidis*, and which can inhibit other pathogenic bacteria such as *Staphylococci* and *Streptococci spp*. This bacterial agent has been found to cause antimicrobial and immunomodulatory (i.e. anti-inflammatory) activity in burns. Firmocidin can be utilized against many burn pathogens such as *S. aureus*, group A and group B streptococcus *Streptococci* \[[@R8]\]. Fusidic acid is a bacteriostatic agent derived from *Fusidium coccineum* fungi. It is capable of suppressing protein production in Gram-positive bacteria such as *Staphylococcus spp*. and *Streptococcus spp*. in burn wound infections \[[@R89]\]. Usnic acid is an antibiotic and anti-inflammatory molecule containing a dibenzofuran structure. Thentimicrobial activity of this compound against Gram-positive bacteria has been reported. Hence, it has been used in treatment of burn wounds \[[@R8], [@R90]\].

Nubiotics are novel antibiotics derived from proprietary protonated nucleic acid and applied against some of infectious pathogens. They were tested in a mouse model of burn wounds infected with a lethal dose of *P. aeruginosa* and gave a significant survival advantage \[[@R91]\]. Biofilms are formed through complex multilayer communities comprised of bacterial cells embedded within a matrix with self-secreting capability, containing extracellular polymeric substance (EPS), proteins and nucleic acids. They exist in an extensive span of natural and artificial environments, which can supply a protective microenvironment for microbial cells. Biofilm-growing cells have been shown to express various set of genes, thus are highly resistant to most antimicrobial treatments. A multilayer biofilm model was described that could be used for testing antimicrobial approaches (such as antibiotic ointments) against burn wound bacterial isolates \[[@R92]\]. The compound 2-aminobenzimidazole (2-ABI) can be found in sea sponges. It can protect the sessile sea sponges against the growth of marine biofilms. 2-ABI analogs exert anti-biofilm activity against biofilms of Gram-negative bacteria such as *P. aeruginosa* \[[@R93]\]. Polyanionic polyphosphate materials can chelate metallic elements including calcium, magnesium, manganese and iron. As a result, they possess antimicrobial activity and are used to treat burn infections \[[@R8]\]. A biofilm destruction device was designed to generate ozone and oxygen at a certain ratio. Ozone has a potent antimicrobial activity and can be used in a controlled concentration to deactivate bacteria and fungi in treatment of burns e.g. *S. aureus* and *P. aeruginosa* \[[@R94], [@R95]\]. D-amino acids also show a dispersal activity against biofilms, and can prevent important microorganisms such as *S. aureus* and *P. aeruginosa* from forming biofilms. These D-amino acids are also generated by the bacteria themselves \[[@R96], [@R97]\]. Dispersin B via an enzymatic anti-biofilm activity cleaves the poly-N-acetylglucosamine molecules, one of the polysaccharide constituents of the biofilm produced by *S. aureus* and *E. coli*, Therefore, this enzyme can be used to treat burn wound biofilms \[[@R98], [@R99]\].

Various mechanisms for development of antimicrobial resistance have been detected in microorganisms \[[@R100]\]. These resistance mechanisms consist of chemical modification of the antimicrobial agent, pumping out the drug from the cells, and modification of the microbial target. Antimicrobial resistance may be an inherent property of the organism, e.g. related to type of the cell wall structure, rendering it resistant, or it may be achieved via mutation in its microbial genome and by acquiring mobile DNA elements such as plasmids from other species \[[@R101], [@R102]\].

3.4 Therapeutic microorganisms {#S15}
------------------------------

Therapeutic microorganisms exert antimicrobial activities against the growth, adhesion of various pathogens to host cells, as well as biofilm generation, and can be used for burn infection therapy \[[@R103]\]. Probiotic bacteria include a group of *Lactobacillus* strains. *L. acidophilus* is commercially available in fermented milk, yogurt and other foods. These bacteria can significantly inhibit Gram-positive and Gram-negative bacterial growth in burns \[[@R104]\]. *Bdellovibrio bacteriovorus* and *Bdellovibrio* like organisms (BALO) are naturally small and motive predatory bacteria belonging to the α- and δ-proteobacteria phylum, which can only replicate inside Gram-negative bacteria, thereby inducing their death \[[@R105]--[@R107]\]. Recently, researchers have tested the activity of BALOs against *E. coli* as well as in burn wound infections caused by *P. aeruginosa* \[[@R108]\].

Bacteriophages as viruses can enter their host bacterium, within which they can replicate, effectively infecting the bacterial cell. Bacteriophage amplification occurs into the host bacterial cells, which enable bacteriophages to be widely used as gene carrier platforms. Different types of phages have specific shape, a diverse loading capacity, a particular mechanism and rate of molecular assembly \[[@R109]\]. Antibacterial phages have been developed due to their efficacy against antibiotic resistant bacteria \[[@R110]\], however the high specificity of phages for their individual bacterial host, means that a cocktail of phages must be used to obtaining any broad-spectrum activity. In a recent study, bacteriophages were utilized for wound infection treatment in mice induced by *Klebsiella pneumonia* suggesting that bacteriophage therapy could be applied for *K. pneumoniae* induced wound infections \[[@R111]\]. In one study, phage therapy was tested in a preliminary clinical trial. Here, a bacteriophage cocktail (BFC-1) was employed to act against *P. aeruginosa* and *S. aureus* in colonized burn wounds. No adverse effects or abnormality was detected due to the phage, opening the way for further investigation \[[@R112]\]. In another clinical trial, phage therapy gave fewer complications, temperature normalization, as well maintained the level of phagocytosis. *Streptococcus* and *Staphylococcus* strains were cultured less often in wound secretions \[[@R113]\]. Elsewhere, a phage cocktail was used against *K. pneumonia-mediated* burn wound infection, and its effectiveness for arresting infection processes without any likelihood of generating resistant strain mutants \[[@R114]\]. Multidrug-resistant *P. aeruginosa* infection has been also illustrated to be controlled in mice through exploiting a lytic phage \[[@R115]\]. In Holguin's work, phage Φ Pan70 showed a significant effect against *P. aeruginosa* infections. Herein, all mice were rescued in the burned model, although the skin lesions remained present in several experimental groups. Thus, bacterial invasion into the blood was hindered by the phages. However, some side-effects such as an intensified immunological response and mastocytosis in the skin was reported at the inoculation site \[[@R116]\].

4. Antimicrobial light and ultrasound-based wound therapy {#S16}
=========================================================

4.1 Phototherapy {#S17}
----------------

Antimicrobial phototherapy (PT) can utilize both visible and non-visible light (ultraviolet and near-infrared), to treat infectious diseases in a minimally invasive manner. Light irradiation has been indicated to cause improvement in the healing process of burn wounds \[[@R117]--[@R123]\]. PT consists of several therapeutic methods such as UV irradiation (200--280 nm), blue light therapy (BLT) (400--470 nm) and low-level laser therapy (LLLT) (390--1100 nm). Also, NP-based photodynamic therapy (PDT) and photothermal therapy (PTT) are promising varieties of phototherapy, which will be discussed in the following sections \[[@R124]--[@R128]\].

Although UV light is supposed to have adverse effects on mammalian cells (e.g. by damaging their DNA) particularly upon prolonged or repeated exposure, several investigations have been conducted that showed that microorganisms are overall much more susceptible to UV inactivation than mammalian cells. Therefore, it has been suggested that UV light could be used as a viable approach for infection therapy \[[@R129], [@R130]\]. UV irradiation damages microbial nucleic acids, and induces repression of the microorganism replication \[[@R131]\]. Investigations have also reported UV light for sterilization and wound care \[[@R132]\]. The chief disadvantage of UV light is its poor penetration into tissue so it can only be used for fairly superficial infections.

LLLT is a non-thermal and non-antimicrobial phototherapy that utilizes laser or light irradiation \[[@R133]\]. LLLT has been tested in studies to treat several disorders, and was shown to increase cellular proliferation, modulate inflammation, and accelerate re-epithelization and repair of the injured skin \[[@R125], [@R134]\]. In one study by Yadav et al. \[[@R117]\] a super-pulsed 904 nm laser (200 ns pulse width, 100 Hz, and mean output power equal to 0.7 mW) was used to increase ATP levels in burn wounds. The results indicated improved aerobic metabolism (by increasing the activity of enzymes e.g. PFK, CS, G6PD, and CCO and higher ATP levels, and lower NADP/NADPH ratio), decreased expression of GS1 and up-regulation of GLUT1 and pAMPKα. These changes led to activation of cellular bioenergetics, regulation of the redox homeostasis and reduced inflammatory response, thus explaining the improved wound healing.

Blue light therapy (BLT) has shown impressive antimicrobial effects, especially for treatment of infected skin wounds including burns. In an investigation, Dai et al. \[[@R118]\] interrogated the mechanism of action of 415 nm blue light in *P. aeruginosa* infected wounds. *P. aeruginosa* cells displayed 35-fold higher levels of killing by blue light, compared to the killing seen with keratinocytes. Results showed intracellular damage to *P. aeruginosa* cells. Using an animal model where the infection could be monitored using bioluminescence imaging, there was a reduced area-under-the-bioluminescence-time-curve after blue light exposure, improved survival rate of infected mice, and negligible damage to the skin and keratinocytes of the mice caused by blue light. Elsewhere, the antimicrobial activity of 415nm blue light was exploited against multidrug-resistant *A. baumannii* infection in mice with third-degree burn wounds. The multidrug-resistant bacteria showed higher blue light-susceptibility than human keratinocytes \[[@R123]\]. Also, other results were reported including blue light-triggered ultrastructural bacterial cell damage, negligible damage to DNA of mouse skin, no resistance to blue light inactivation, and highly attenuated bacterial burden in mouse tissue samples.

Furthermore, green light has also been the subject of some studies. Catão used green LED light to tackle skin burns in rats by exerting anti-inflammatory effects. The results showed a substantial decrease in inflammatory cells \[[@R119]\].

Far-infrared (FIR, 3um-100um) light has also shown beneficial effects on wound healing. In a research by Chiu et al., the exploitation of FIR reduced NLRP3 inflammasome activity and IL-1β generation caused ASC ubiquitination (a regulatory role of inflammasomes), followed by enhanced transport of inflammasomes to autophagosomes. FIR irradiation also lessened the infiltration of inflammatory cells, prevented loss of specific collagen fibers, and burn-triggered epidermal thickening, as well enhanced autophagy. Hence, these results suggested FIR could promote burn wound healing \[[@R120]\]. In another study, a single exposure of a low power laser (830nm) equal to3 J/cm^2^ was applied to thermally-injured Swiss albino mice. Histological and immunohistochemical analyses indicated improved tissue healing in the NIR-illuminated mice, and regulation of several cellular markers \[[@R122]\].

Recently, low power laser (LPL) and LED have been employed to realize the molecular mechanisms related to epidermal healing in burn wounds. The results signified efficacy of 660nm LPL and 850 nm LED to decrease oxidative stress levels and lower expression of IL-6 and pERK1/2, leading to downregulated inflammatory responses, less dermal necrosis, and enhanced granulation tissue generation, subsequently all causing betterment of burn wound healing process \[[@R121]\].

4.2 Shockwave and ultrasound based-therapy {#S18}
------------------------------------------

Therapeutic shockwaves and ultrasound have been indicated to have advantageous effects on wound treatment, thus to accelerate the wound healing process in burns. recently, Rünzler et al. indicated the efficacy of shockwave treatment for wound healing by activating purinergic ERK1/2 signaling pathways by inducing ATP release, and then enhancing cell proliferation \[[@R135]\]. In another study, Fantinati et al. investigated chronic third-degree burn wounds and reported that low-intensity ultrasound could control the extent of tissue necrosis, enhance granulation tissue formation, as well as accelerate wound closure (via contraction). They suggested that ultrasound would have useful effects on the inflammatory and proliferative phases in burn treatment process; but could induce undesirable angiogenesis as well as inflammation in the remodeling phase \[[@R136]\].

5. Stem cell based-burn therapy {#S19}
===============================

Considering their regenerative ability, stem cells have been regarded as a versatile and efficacious therapy in biomedicine \[[@R137]\], and could provide new solutions for many diseases including, osteoporosis, osteoarthritis, cartilage regeneration, and cardiovascular. In the case of wound treatment, the combination of stem cells with nanostructures has opened up new horizons. Stem cells can be distinguished from other kinds of cells by three main attributes: 1) renewability and ability to divide themselves for prolonged periods of time; 2) they are non-specialized cells; and 3) they potentially can differentiate into miscellaneous specified cell types. Diverse stem cells derived from humans and animals have been reported including induced pluripotent stem cells (iPSCs), non-embryonic \"somatic\" or \"adult\" stem cells, and embryonic stem cells. In this regard, stem cells have shown promising potential to treat burn wounds.

Stem cells can improve wound healing through differentiation into skin cells, by a pronounced anti-inflammatory effect and by stimulating angiogenesis. Foubert et al. \[[@R138]\], for instance, found acceleration of re-epithelialization in treated wounds by using adipose-derived stem cells (ASC). Subsequently, an increase in blood vessel density and deposition of ECM (collagen) was indicated. Directly injecting stem cells into the wound, or their intravenously administrating both led to comparable beneficial outcomes.

Yang et al. \[[@R139]\], showed epidermal stem cells that overexpressed the EGF-like domain 7 (EGFL7-ESCs) could stimulate fibroblasts to proliferate and migrate, and this effect could be used for enhanced healing of wounds. Bliley et al. \[[@R140]\] employed adipose derived stem cells (ASCs), and demonstrated an enhancements in the mRNA expression of collagen (type I and III), collagen deposition vascularity, which eventually followed by adipogenesis. They suggested ASCs could have a vital role as an adjunctive therapy for full-thickness burn wounds.

Recently, in a research \[[@R141]\],bone marrow--derived mesenchymal stem cells (BM-MSCs) migration into the burn wound margins enhanced the re-epithelialization, as well, the mobilization of BM-MSCs was regulated via CXCL12/CXCR4 signaling.

In another study \[[@R142]\] allogeneic MSCs were shown to improve burn wound healing via reducing unhealed areas, and enhancement of the dermal thickness, epidermal area and collagen content. In a study by Chen et al. \[[@R143]\], adipogenic differentiated ASCs (using +3-isobutyl-1-methylxanthine (IBMX) \[D1--5\]+INSULIN) enhanced early wound better compared to ASCs, as well as decreasing fibrosis and inflammatory infiltration in the superficial dermis.

6. Nanotechnology for treatment of burn infections and wound healing {#S20}
====================================================================

Treatment of burn wound infections and skin regeneration are complex processes, and have been researched for decades. Recently the rise of antibiotic-resistant pathogenic microorganisms has correlated to greater resistance to topical antimicrobial agents in burn injuries, which is regarded as an important threat to public health. Hence, developing new even more potential antimicrobial agents is a necessity. Nanotechnology has introduced particles made of a wide variety of materials, but what they have in common is a size range of 10--1000 nm \[[@R144], [@R145]\]. Nanotechnology has been called "a new paradigm" in medicine, and new therapeutic methods based on NSs have been developed to tackle many diseases \[[@R146], [@R147]\], particularly burn wounds and burn infections. Nanomedicine can lead to effective improvements in therapy for infected burns in the post-antibiotic era and better skin regeneration \[[@R148]\]. In this section, we review new nanotechnology-based approaches for of burn infection treatment and healing of wounds. NSs have shown impressive antimicrobial activities against resistant strains of microorganisms, and are also capable of accelerating regeneration of burn-injured skin \[[@R149], [@R150]\]. NSs utilized in burn therapy can be classified as two main groups: organic NPs and inorganic NPs; each of which contains diverse types of NPs utilized for burn infections infection and wound healing \[[@R151], [@R152]\]. Organic NSs include polymeric NPs, nanoemulsions, nanogels, liposomes, micelles and solid lipid-based NPs (SLBNs), while inorganic NSs contain nanocarbons, AuNPs, CuNPs, AgNPs, TiO~2~ NPs, magnetic NPs (MNPs) and quantum dots (QDs). Nanocarbons comprise fullerenes, carbon nanotubes (CNTs), graphene, nanodiamonds, etc. \[[@R150], [@R153]\]. Furthermore, in recent years, NS-based structures such as nanofibers (NFs), 3D-scaffolds and films have been developed for wound therapy, which also will be discussed in the following sections.

6.1 Therapy of burn wound infections using NSs with antimicrobial effects {#S21}
-------------------------------------------------------------------------

### 6.1.1 Organic NPs {#S22}

Polymeric NPs can be fabricated through implementing various materials, and methods. They are conventionally synthesized via self-assembly of ingredients such as chitosan (CS), curcumin, poly lactic-co-glycolic acid (PLGA), as well as having different shapes including dendrimers, hydrogels and Nanomicelles (NMs) \[[@R154]\]. Polymeric NPs have been utilized in different biomedical applications \[[@R155], [@R156]\]. They are usually synthesized by self-assembly of charged polymers mediated by interactions between chains with cationic and anionic groups. This is a relatively mild process and will not damage cargo components such as proteins that would be deactivated by high temperatures and organic solvents. These methods use an emulsification process to synthesize polymeric NPs. Such methods can be used as a strategy for production of others polymeric NPs incorporating therapeutic nucleic acids, peptides or proteins inside the NPs \[[@R157]\]. KGF is a potent growth factor involved in re-epithelization of skin wounds \[[@R158]\]. In two recent investigations it was shown that that KGF contained in self-assembled NPs could stimulate healing of skin wounds, giving increased re-epithelization, better tissue remodeling and skin regeneration \[[@R159], [@R160]\]. PLGA is a FDA approved material used in the production of polymeric NPs (100--200 nm) due to its advantages including biodegradability, biocompatibility and non-toxicity \[[@R161]\]. PLGA NPs are normally fabricated by emulsification of hydrophobic components, using an organic solvent and various surfactants \[[@R162]\]. In one study, PLGA was used to manufacture EGF-loaded NPs for wound healing. Full-thickness wounds treated with EGF-loaded PLGA-NPs gave the highest level of fibroblast proliferation and the fastest healing \[[@R163]\]. Researchers have reported that PLGA could provide a biocompatible system for delivery of growth factors. In one study, the delivery of the host defense peptide called LL37, incorporated into PLGA NPs reduced the release of lactate and accelerated wound healing \[[@R164]\]. Studies have clearly indicated that PLGA-NPs loaded with LL-37 antimicrobial peptide could be utilized as an effective agent against (polymicrobial) infected wounds \[[@R164], [@R165]\]. CS NPs (150--300 nm) usually are made of pristine soluble CS by using ionic gelation methods. CS can be employed as a natural and safe biodegradable substance in the design of drug/gene delivery systems \[[@R166]\]. Recently, CS due to considerable advantages has been utilized in burn wounds, and fabrication of haemostatic dressings, bandages, etc. In addition, CS can also be used as a prophylactic agent that prevents the progression of infections, and has also been described to produce significant acceleration of wound-healing \[[@R167]--[@R169]\]. Because CS is a cationic polymer, CS NPs have been used as intrinsic antimicrobial agents for prevention of microbial infections \[[@R170], [@R171]\]. Many studies have reported that CS NPs and analogs could facilitate wound treatment process by increasing the function of inflammatory cells in the wounds, and stimulating fibroblasts and osteolasts \[[@R172]\]. In two independent studies, it was shown that CS NPs could facilitate coagulation by attaching to red blood cells, and improve inflammatory cell functions. In addition, CS NPs are used as components of dressings and bandages designed for skin wounds to support the mechanical strength of the wound, and increase the wound healing rate both in humans and animals \[[@R169], [@R173]\]. In another research, CS NPs were employed for the preparation of films in combination with alginate, and loaded with SSD cream to treat infected open wounds \[[@R174]\]. Curcumin NPs, are formed from curcumin (40--200 nm), which is a natural yellow pigment with a diarylheptanoid structure, an example of curcuminoid-related molecules extracted from turmeric, a spice prepared from the root of *Curcuma longa*, which has been exploited in traditional medicine for centuries \[[@R175]\]. Encapsulation of curcumin into NPs is an advantageous delivery method for this water-insoluble substance. In one study, curcumin NPs were found to have strong antibacterial activity to suppress the growth of *P. aeruginosa* and *S. aureus*, and treat skin infections in mouse wounds \[[@R176]\]. In other studies, it was found that curcumin NPs could reduce inflammation and induce cell expansion that was useful in reconstruction of damaged tissue \[[@R177]--[@R179]\].

#### • Dendrimers {#S23}

Dendrimers are a type of nano-scale (1--10 nm) polymeric macromolecule with a homogeneous and monodisperse structure, which have applications in both diagnosis and therapy. Dendrimers possess a symmetric core, an inner shell and an outer shell. Dendrimers can be prepared from phenyl acetylene subunits \[[@R180], [@R181]\]. Moreover, the surface functional groups of dendrimers can act as antibacterial agents themselves (especially if cationic). In one study, the interaction of the positively charged groups of a dendrimer (quaternary ammonium groups) and the negatively charged groups of the bacterial cell wall could lead disruption of the bacterial structure. Moreover water-soluble dendrimers such as polyamidoamine -based dendrimers can be loaded with water-insoluble antibiotics (e.g. nadifloxacin and prolifloxacin), which increases their bioavailability and enhances their antibacterial properties \[[@R181]\]. In another approach, silver-dendrimeric NSs were found to have synergistic effects in terms of anti-inflammatory and antimicrobial activity; dendrimers were shown to be an ideal carrier to diminish inflammation, while disinfecting the wound and stimulate healing \[[@R182]\].

#### • Hydrogels {#S24}

Hydrogels as polymeric networks are regarded as hydrophilic three-dimensional structures, which potentiate absorption of large amounts of aqueous fluid. Because they have high porosity and a soft consistency, they can be used for dressings and to help tissue regeneration \[[@R183]\]. These materials are ideal for wound dressings, because they can protect the injured tissues make the patients more comfortable as they exert a cooling function, and their non-adhesive nature preserves the wound tissue \[[@R184]\]. Recent advances have shown that hydrogel NPs combined with other components including CS, keratin, PVA, PEG, AMPS, PEGDA, self-assembled peptides, dextran, hyaluronan, collagen, fibrin and antibiotics can induce skin regeneration in burns. \[[@R185]\]. In one study, the antimicrobial activity and scar preventive (antifibrotic) properties of hydrogels were optimized for wound dressings using a coating comprised of a combination of PVP, PEG and CS coated onto a cotton fabric. A model drug, tetracycline hydrochloride was loaded in the hydrogel structure. The Cumulative drug release was indicated to be 80% over 48 hours, followed by improved antimicrobial effect of the dressings against both Gram-positive and Gram-negative bacteria, and minimal scarring when the dressing was applied to wounds \[[@R186]\]. Hydrogels also possess other features making them substantially invaluable for tissue regeneration and engineering. A 3D network-like matrix composed of hydrogel behaves more like natural biological ECM to allow cell growth, compared to cells seeded on two-dimensional substrates \[[@R187]\]. The nanoplatforms can be modulated to release various bioactive molecules such as antibacterial agents, growth factors, and cytokinesin tissue damage site, as well to assist beneficial implementation of exogenous epithelial cells, fibroblasts or stem cells \[[@R188], [@R189]\]. Recently, basic fibroblast growth factor (bFGF) transport by gelatin-based hydrogels, and their subsequent release were reported to help the healing of acute vocal fold damage without scarring. Using this bFGF hydrogel-based treatment enhanced tissue regeneration \[[@R190]\]. In another study, ionic micellar NPs were designed using chitosan with hydrophobic modifications, combined with fatty acids, which undergo self-assembly in aqueous medium. Results indicated biocompatibility of the NPs, successful encapsulation of a poorly-soluble drug (clarithromycin), and the ability to be administered both parenterally and topically. Thus, this nanoplatform was suggested to be beneficial for skin regeneration and wound healing \[[@R191]\].

#### • Nanoemulsions {#S25}

Nanoemulsions (NEs) are made of oil-based and aqueous solutions forming nano-sized particles in the range of 20--200 nm \[[@R192]\]. NMs are generally made of amphiphilic molecules that adopt a spherical form in aqueous solutions \[[@R193]\]; they have two parts including a hydrophobic core as well as a hydrophilic coating. The hydrophobic core can be efficiently loaded with insoluble agents, and the hydrophilic coating allows the NPs to be soluble in aqueous media \[[@R194]\]. The aqueous phase of NE contains water and co-surfactants e.g. glycerin and ethyleneglycol. NEs can be produced via mixing the constituents using ultrasonication and stirring. In one study, chlorhexidine acetate formulated in a nanoemulsion was used against a methicillin-resistant *S. aurerus* (MRSA) infection in a skin burn wound model. Here, the nanoemulsion showed effective and rapid activity against MRSA in-vitro and in-vivo and hindered formation of biofilm, disrupted MRSA cell walls, led to increased leakage of DNA, protein, Mg^2+^, K^+^ and alkaline phosphates out of the cells \[[@R195]\].

In another study, a CS film was impregnated with NEs encapsulating eucalyptus oil, produced by an emulsification method, which showed a good antibacterial effect against *S. aureus*. The mechanism of action of this eucalyptus oil-NE-CS film was attributed to cell membrane damage, and wound healing efficacy to a non-irritant activity in the wounds \[[@R196]\]. NMs made via self-assembly have been recently used to encapsulate hydrophobic drugs to improve their solubility \[[@R197]\]. Recently, ionic micelles have been fabricated using ionically-modified CS, and loaded with SSD as an antimicrobial. These micelles were also loaded with platelet lysate and used for treatment of chronic burn wounds. Unloaded CSs demonstrated good biocompatibility against fibroblasts. High concentrations of SSD could be obtained using the micelles as well as reduction in the cytotoxicity and bio-incompatibility of SSD towards fibroblasts, and improvement in the the activity PDGF-AB (platelet derived growth factor (PDGF-AB) \[[@R198]\].

#### • Liposomal NPs {#S26}

Liposomal NPs consist of spherical vesicles made of one or more lamellar lipid-bilayers that spontaneously self-assemble when amphipathic precursors are mixed. Unilamellar liposomes have a single shell, while multilamellar liposomes have several concentraic shells. These bilayers can be produced from cholesterol and naturally occurring phospholipids including phosphatidylcholine \[[@R199]\]. One study reported that dihydroquercetin formulated as a liposomal nanocomplex could improve endogenous antioxidant activity, reduce the necrotic area in burned skin, and finally induce better healing \[[@R200]\]. Elsewhere, the use of other liposomal components e.g. DOTAP/cholesterol for encapsulating DNA ending the IGF-I and KGF genes into dermis and epidermis was reported to be an effective method to improve epithelial cell differentiation and expansion \[[@R201], [@R202]\].

SLBNs have been tested as potential drug delivery systems (DDSs) that could be topically administered to the skin and eyes, or else delivered by parenteral, oral, and inhalational routes. SLBNs can be classified into two main groups including solid lipid NPs (SLNs) and nanostructured lipid carriers (NLCs). Various methods have been developed for synthesis of these NPs including microemulsion, solvent emulsification, evaporation, and high pressure homogenization \[[@R203]\].

SLNs are solid colloidal drug delivery vehicles at room temperature, made of solid lipids, instead of the liquid lipids that are used in NEs. SLNs made from spherical solid lipids can also include hydrophilic molecules such as PEG derivatives, and can be stabilized using surfactants. These vehicles have been suggested to be as an alternative to, microparticles, liposomes, and emulsions. It has been also shown that coating SLNs with hydrophilic agents enhances their plasma stability and improves the bioactivity of drug-loaded SLNs \[[@R204]\]. Several types of drugs can be delivered to chosen organs with high specificity using ligand-targeted or stimulus-responsive SLNs such as antibody-SLN conjugates, magnetic-SLN, pH sensitive SLN and cationic-SLN \[[@R205]\]. In one study, SSD-loaded-SLNs were tested for prolonged release of the cargo, and to reduce the pain in severe skin wounds. In addition, the use of SLNs increased cell migration and improved wound closure ratres \[[@R206]\]. Another study used a novel cell-based 3D-wound treatment approach, showing that empty SLNs facilitated re-epithelialization with low cytotoxicity and no irritation. Moreover these NPs could also encapsulate and allow release of morphine in a wound dressing \[[@R207]\]. In another investigation, SLNs loaded with nitrofurazone acted as a delivery vehicle to get topical drug into the burn eschar, to improve the antimicrobial activity of nitrofurazone for treatment of infection in burn patients \[[@R208]\].

The second generation of SLNs, called nanostructured lipid carriers (NLCs) are comprised of both solid and liquid components, and have a higher drug-loading capacity and better stability \[[@R209], [@R210]\]. NLCs are comprised of physiologically biocompatible, and biodegradable and lipids and surfactants \[[@R211]\]. NLCs can be used to deliver highly lipophilic drugs into targeted organs, and damaged tissues such as burn wounds \[[@R212]\]. Miconazole-encapsulated NLCs were recently used to enhance miconazole activity (a poorly-water soluble antifungal agent). It was reported that the miconazole-encapsulated NLCs displayed enhanced antifungal activity against *Candida albicans* yeast cells \[[@R213]\]. In recent studies, emulsified recombinant human (rh)EGF-loaded into NLCs by ultrasonication was indicated to improve wound healing, as well to stimulate fibroblast expansion and collagen production \[[@R214], [@R215]\]. These rhEGF-loaded NLCs are potential candidates for healing of chronic wounds and burns. In a study by Gainza et al., dressings were fabricated in the form of fibrin-based solid scaffolds or semi-solid hydrogels, and loaded with lipid NP-encapsulated rhEGF. The growth factor underwent sustained release into wounded skin. The fibrin-based scaffolds were suggested as the best approach for rhEGF delivery due to their superior prolonged stability \[[@R216]\].

### 6.1.2 Inorganic NPs {#S27}

#### • Metallic NPs {#S28}

Metallic NPs mostly consist of AuNPs, CuNPs, and AgNPs have been employed in wound healing researches. Recently, the therapeutic activity of phytochemical-decorated AuNPs (Phyto-AuNPs) was studied for treatment of surgical wounds and burn wounds in a rat model. The Phyto-AuNPs were shown to act as an efficient antioxidant that could stimulate high expression of the pro-angiogenic agents (VEGF and Ang-2) thus improving skin regeneration. These Phyto-AuNPs were also suggested to be useful for healing of burn wounds \[[@R217]\]. In a similar study, cryopreserved human fibroblast cells (CrHFC) cultured with AuNPs were used to treat third-degree skin burns in white male rats. CrHFC-AuNPs facilitated skin repair and improved collagen production by the third week after treatment \[[@R218]\]. Interestingly, a novel modifiable collagen-gelatin fleece also improved burn wound healing without any added AuNPs \[[@R219]\]. In another study, AuNPs-incorporated collagen scaffolds (AuNP-SCs) were designed and cross-liked with glutaraldehyde. Use of AuNPs, allowed the scaffolds to have good biocompatibility, high mechanical strength, enhanced stability against enzymatic degradation, and reduced hydrolytic activity, compared to non-AuNP-incorporated scaffolds. Cross-linked AuNP-SCs inhibited inflammation and greatly improved the granulation tissue generation, and produced more neovascularization.

Wound closure was improved for both cross-linked AuNP-SCs and non-Au containing scaffolds and the AuNP-SCs were suggested as a potent skin substitute for coverage of wounds \[[@R220]\]. Cu is considered to possess a broad-spectrum antimicrobial activity against bacteria, yeasts as well as viruses \[[@R221]\]. Despite its beneficial properties, Cu can damage proteins (especially lipoiproteins), can cause rapid oxidation reactions in unsaturated lipids, therefore there is a possibility of Cu causing cytotoxicity and tissue damage. Thus the use of innovative nanotechnology-based methods are essential to diminish the side effects of Cu, while still allowing it to act as a powerful antimicrobial agent. Recently, one study showed that CuNPs were effective antimicrobial agents against *E. coli, S. aureus, Micrococcus luteus, K. pneumoniae, P. aeruginosa* as well as fungi such as *Aspergillus flavus, Aspergillus niger* and *Candida albicans*: all of these species are commonly found found in burn wounds \[[@R222]\]. A similar study examined Cu-encapsulated-CS-NPs for antimicrobial applications. As mentioned previously, CS is a natural antimicrobial polymer, that could exert synergistic activity between Cu and CS NPs \[[@R223]\].

For decades silver nitrate and SSD have been utilized as topical antimicrobial agents in burn wound treatment. Recently nano-scale silver-containing platforms such as AgNPs, and Ag-containing hydrogels have been applied in burn wound therapy. Two recent studies found that hydrogels containing AgNPs were a potent alternative to SSD for healing of burn wound infections, without causing cytotoxicity \[[@R224], [@R225]\]. In another study, AgNPs were used as an antimicrobial material for healing of skin wounds, where also showed a good antimicrobial effect and the capability to be used in wound dressings \[[@R226]\]. In a similar study, AgNPs loaded with additional components such as enoxaparin (a low molecular weight heparin used as an anticoagulant) were used to induce anti-inflammatory and angiogenic activity for wound treatment. The enoxaparin-loaded AgNPs could shorten the healing time of the wounds \[[@R227]\]. In a similar study, cotton fabrics containing stable 22 nm diameter AgNP suspensions were used as wound dressings and with effective antimicrobial and anti-inflammatory functions. Here, 250 ppm AgNP-containing cotton fabric demonstrated good anti-microbial activity compared to fabric containing less (60 and 125 ppm) AgNPs. Furthermore, using AgNPs led to same healing consequences in comparison with Dermazin® cream (SSD), and an anti-inflammatory effect, the same as indomethacin drug with dose of 20 ml \[[@R228]\]. In another study, an AgNP-based dressing with 3D-cultured fibroblast cells was used for full-thickness skin damage in burned patients. The results indicated that AgNPs reduced mitochondrial activity without activating cell death mechanisms, as well In vivo results showed AgNPs were localized in the cytoplasm of fibroblasts with no cytotoxicity evident \[[@R229]\]. The presence of normal human epidermal keratinocytes (NHEKs) and normal human dermal fibroblasts (NHDFs) is essential for good wound healing, but because they synthesize interleukin 12 (IL-12), TNF-α, and VEGF, they can cause excessive inflammation in the first two days. AgNPs could decrease the secretion of VEGF and pro-inflammatory cytokines. The results indicated NHEKs were more susceptible to AgNPs than NHDFs \[[@R230]\].

#### • Carbon-based NPs {#S29}

Carbon-based NPs include CNTs, fullerenes, graphene, nano-diamonds and so forth. CNTs have recently been studied as novel drug and gene delivery platforms \[[@R231]\]. The molecular structure of CNTs is extremely hydrophobic, and CNTs are highly prone to aggregation. Nevertheless they can be attached to biomolecules by covalent and non-covalent bonds and used as delivery vehicles. CNTs have also been explored as potential antimicrobial agents with an intrinsic antibiotic function. \[[@R232]\]. In one research, Cu/Zn bimetallic NPs were combined with carbon nanofibers (CNFs) as a novel antimicrobial agent for wound dressing and burn healing. This antibacterial platform suppressed the growth of Gram-negative bacteria and Gram-positive bacteria e.g. E. coli and methicillin-resistant MRSA, respectively \[[@R233]\]. In one study, SWCNTs showed effective bactericidal activity against bacteria e.g. *Salmonella enterica* and *E. coli*. Here, SWCNTs caused the aggregation of bacterial cells and led to death of the microorganisms. Fullerenes have also shown an intrinsic antimicrobial function against different bacteria such as *E. coli, Salmonella* and *Streptococcus spp*. This antibacterial activity may be due to inhibition of energy metabolism and impairment of respiration by entry of the NPs into the cytoplasm \[[@R234]\].

Graphene is defined as a single monolayer of carbon atoms forming a two-dimensional crystal, with derivatives such as graphite oxide (GO). GO is hydrophilic (while graphene itself is highly hydrophobic) and can be produced by chemical modification of graphene. Graphene and GO NSs have been reported as appropriate carriers of drugs while showing antimicrobial activity against microbes such as *E. coli., S. aureus, P. aeruginosa* and *C. albicans*, besides can be exploited for fabrication of wound dressings and also for water disinfection \[[@R235]\]. In one study, it was reported that GO NPs could interact with bacteria, causing RNA efflux, and could disrupt cell membranes of Gram-negative bacteria and Gram-positive bacteria \[[@R236]\]. The povidone-iodine complex (PVPI) has a potent antiseptic activity against several microorganisms e.g. *E. coli*. In one study, SWCNTs were coated with PVPI to produce water-soluble and stable structures with monolayer polymeric helical coil morphology. Eventually, a composite film composed of these NSs served as a conductive bandage for skin wounds with improved flexibility, besides demonstrating the slow-release of antiseptic iodine \[[@R237]\].

#### • QDs {#S30}

QDs are semiconductor nanocrystals with a three-dimensional structure and a tunable luminescence emission in any color, that are widely as fluorescent dyes and reporters in biomedicine \[[@R238]\]. Graphene QDs (GQDs) were shown to have an intrinsic peroxidase-like activity, whereby they functioned as a catalyst similar to an enzyme. The GQDs were able to generate hydroxyl radicals from hydrogen peroxide. Therefore, since •OH has a potent antibacterial activity, the reaction of H~2~O~2~ to produce •OH dramatically increased the antibacterial function of H~2~O~2~ meaning that high concentrations H~2~O~2~ in the wound were not needed and host toxicity was reduced ([Figure 4](#F4){ref-type="fig"}) \[[@R239]\]. In another research, antibiotic NSs were fabricated comprised of AgNPs combined with GQDs coated with PEGylation and produced by a laser synthesis process. The antibacterial activity of Ag-GQD complexes was evaluated against bacteria including *S. aureus* and *P. aeruginosa*. Ag-GQDs acted as an antimicrobial agent with synergistic activity of its two components \[[@R240]\].

#### • Ceramic NPs {#S31}

Ceramic NPs include oxides, carbides, phosphates, carbonates, calcium, and generally have porous structures such as silicon oxide (silica) and aluminum oxide (alumina) \[[@R241], [@R242]\]. They have a wide range of industrial, diagnostic, and therapeutic applications because of their high heat resistance and chemical inertness. Targeted ceramic NPs have been explored as potential carriers for drugs, genes, proteins, imaging agents and photosensitizers in a broad span range of biomedical applications. Ceramic NPs have also been utilized as drug delivery platforms to enhance antimicrobial activity against pathogens \[[@R243], [@R244]\]. In one study, the antibiotics gentamicin and rifamycin were loaded into silica NPs immobilized inside collagen-hydrogels, and were used to treat wound infections and to evaluate their antibacterial activity against *P. aeruginosa* and *S. aureus* wound pathogens. Results indicated the gentamicin-loaded silica NPs embedded in collagen hydrogels could significantly improve wound healing and demonstrated a long-lasting antibacterial activity, with low cytotoxicity toward fibroblast cells. On the other hand, the rifamycin-loaded silica NPs in collagen hydrogels showed no bactericidal activity, because of intense absorption of rifamycin onto the collagen fibers and no subsequent release \[[@R245]\]. As mentioned above NO is an antimicrobial agent that can prevent infections developing in burn wound sites \[[@R246]\]. Recent studies have assessed the potential of NO-loaded silica NPs to act as an antimicrobial agents against various microorganisms in burn infections. Delivery of high doses of NO-loaded silica NPs has been shown to inhibit fibroblast proliferation compared to clinically relevant doses of NO. Furthermore, these NO-NPs have been shown to have antimicrobial activity against biofilms \[[@R246], [@R247]\]. TiO~2~ NPs show antibacterial activity upon UV irradiation due to ROS generation by the process known as photocatalysis. The aggregates/agglomerates of TiO~2~ NPs greater than 100 nm in diameter could not photo-inactivate *E. coli* and *Saccharomyces cerevisiae*, but conversely were able to act as a "sunscreen" and protect the microbial cells from inactivation by UV light alone \[[@R248], [@R249]\]. In one study, ZnO and TiO~2~ NPs demonstrated a strong inhibition against some species of bacteria including MRSA biofilms \[[@R250]\]. In another study, TiO~2~ NPs were applied as an antibacterial agent against Gram-negative and Gram-positive bacteria to improve wound treatment. Furthermore, the "green-synthesized" TiO~2~ NPs extracted from *Moringa oleifera* in a pH and temperature dependent process, stimulated wound healing in rats \[[@R251]\]. In a similar research, films equipped with green TiO~2~ NPs, isolated from the plant *Psidium guajava*, exhibited an antibacterial and antioxidant mechanism against *E. coli* and *S. aureus* \[[@R252]\]. In another investigation, the antimicrobial activity of TiO~2~ NPs and the related mechanism of action against *P. aeruginosa* was studied \[[@R253]\].

6.2 Nanofibers {#S32}
--------------

Nanofibers (NFs) are fabricated from natural and synthetic continuous polymer chains. Nanoscale biodegradable NFs can enhance cellular and drug interactions with scaffolds used in tissue regenerating and engineering as well anti-microbial drug delivery applications. NFs with a diameter near 5 nm, can emulate collagen in size and the fibril structure that exists in the ECM. Hence, these NFs have been applied as beneficial nano-textured materials and scaffolds in burn wound care. NFs can be fabricated with diverse pore sizes, diameters and density \[[@R254], [@R255]\].

Electrospinning is a well-known technique to produce electrospun biodegradable NFs \[[@R256]\]. In this technique, a charged liquid jet of substrate is injected into a quickly rotating collector. Subsequently, the NFs is fabricated taking advantage of an electrostatic charge imbalance that overcomes the surface tension of the solution and the solvent is evaporated \[[@R257]\]. Regarding the high area to volume ratio of electrospun NFs, they can increase transfer of various molecules e.g. antibacterial agents, anticancer drugs, nucleic acids, and diverse growth factors, as well improve cellular attachment to tissues. Thus, electrospun NFs have been extensively employed in the form of NFs scaffolds used in tissue regeneration and tissue engineering \[[@R258]\]. In a study, Jayesh et al. loaded the iron chelator 2,3-dihydroxybenzoic acid (DHBA) within poly D, L-lactide (PDLLA)-poly ethylene oxide (PEO) NFs (called DF) created by electrospinning. They used DF for therapy of chronic infections induced by *P. aeruginosa* biofilms in wounds. Thus it was found that DF could decrease biofilm creation by nearly 75% in 8 h and could be incorporated into a wound dressing to cure *P. aeruginosa* chronic infections. Here, DHBA was released from DF for 4 h, comparable to the time needed for bacterial growth inhibition \[[@R259]\].

Copper can be incorporated in the regeneration and healing of damaged tissue. Cu can increase integrin expression (as an adhesive molecule), collagen fabrication and fibrinogen stabilization \[[@R260]\]. More recently, a copper containing NF structure (326 ± 149 nm in diameter) fabricated via electrospinning of PDLLA and poly-ethylene oxide PEO was shown to inhibit *S. aureus and P. aeruginosa* biofilm formation, by 41% and 50%, respectively \[[@R261]\].

NFs can be also fabricated by thermally induced phase separation (TIPS). In a study Li et al. generated a silk fibroin-PLGA NF scaffold (to mimic the ECM) by the TIPS method for a wound dressing. This structure showed the highest equilibrium water uptake rate of 72.2% and a water vapor transmission rate of 5591.88 g/m^2^ per day. Furthermore, the optimum properties of silk fibroin-PLGA NF scaffolds including water vapor permeability, water uptake rate/loss rate (to absorb wound skin humidity for suppression of wound infection and protection of damaged skin humidity) were achieved at the weight ratio of 8/8. The scaffolds were also reported to show sustained release of curcumin (as a model drug). \[[@R262]\].

Shape memory polymer--based NFs can be designed to control drug release, and as smart wound healing dressings are able to be applied for chronic wound healing and regeneration of damaged skin \[[@R263], [@R264]\]. In a study, Tan et al. generated a multifunctional and smart electrospun-based NF for wound repair. They fabricated the NF from chitosan, gelatin and shape-memory polyurethane, loaded with silver nitrate (AgNO~3~). The antibacterial activity of the NF was evaluated against bacteria including *E. coli, P. aeruginosa* and *S. aureus.* The results demonstrated higher antibacterial activity against *E. coli* and *P. aeruginosa* compared to *S. aureus* \[[@R265]\].

In a recent research, dendrimers (as branched monodisperse nanoscale molecules) were incorporated in a NF structure due to properties such as biocompatibility, flexibility, solubility, chemical stability, etc. Here, Dongargaonkar et al. designed electrospun blends, comprised of gelatin and highly branched star-shaped polyamidoamine dendrimer covalently conjugated to gelatin. Silver acetate (0.83, 1.65, and 3.30% w/w) as an antibacterial agent was loaded into the constructed NFs. Silver was shown to be significantly released at 48 h. antibacterial activity of the NF was evaluated on *S. aureus* and *P. aeruginosa* at 37 °C for 4, 24, and 48 h. In control groups including a blend of gelatin and silver acetate, *S. aureus* and *P. aeruginosa* showed rapid growth for 4 and 24 h while in active groups, *S. aureus* and *P. aeruginosa* growth was completely inhibited by silver acetate released from the constructed NF in 4 h. Thus, dendrimers covalently associated to gelatin both increased loading capacity as well bestowed immense flexibility to NFs as a candidate for dressing materials \[[@R266]\].

6.3 3D-scaffolds, films and wound dressings {#S33}
-------------------------------------------

New platforms including 3D-scaffolds, engineered films and hi-tech wound dressings are regarded as promising materials for tissue engineering, and improved results have been reported in wound healing studies. For example, ASC-containing PEGylated fibrin-based gel scaffolds used as a construct for wound coverage were shown to improve burn wound healing. Using this scaffold, ASCs were still present at the wound site 14 days after wound initiation. The scaffold enhanced the vascularization and attracted mannose receptor-expressing cells into the wound, improved the generation of granulation tissue as well as early mononuclear cell recruitment, but did not show any negative effects on wound closure. [Figure 5](#F5){ref-type="fig"} shows the measurements of wound size 1, 2, and 3 weeks after initiation of burn injury ([Figure 5-a](#F5){ref-type="fig"}), the wound thickness 1 and 2 weeks after initiation of burn injury ([Figure 5-b](#F5){ref-type="fig"}), the area occupied by nuclei 1 week after the injury initiation ([Figure 5-c](#F5){ref-type="fig"}) and of blood vessel quantification in regenerating areas of the wound site 1 week after the initiation of the burn injury ([Figure 5-d](#F5){ref-type="fig"}) \[[@R267]\].

Bacterial cellulose (BC) is defined as a natural polysaccharide with well-known beneficial properties such as biocompatibility, biodegradability, mechanical strength, nanofibrillar structure, moldability, water absorbency, porosity, and noticeable biological affinity in general. The ability of BCs to play a role in the fabrication and construction of 3D-scaffolds applied for tissue regeneration and healing has been reported \[[@R268], [@R269]\].

In the literature, various reports of a diverse assortment of films/membranes acting as wound healing dressings have been published. For example Cu^2+^-loaded bioactive glass/eggshell films \[[@R270]\], NO-releasing CS films \[[@R271]\], and Ag/ZnO-microporous CS composite dressings \[[@R272]\]. All these have resulted in substantial improvements in antibacterial activity, angiogenesis, re-epithelialization, skin reconstruction, blood clotting ability, and so forth leading to improved wound healing. Particularly concentrating on burn wounds, miscellaneous dressings have been reported such as Ag^+^ sulfadiazine-containing nanosheet-based ultra-thin films \[[@R273]\], NO-releasing polymeric films \[[@R274]\], tyrothricin (cyclic polypeptide antibiotic)-containing CS-based film-forming gel layers \[[@R275]\] with particular advantages including insignificant cytotoxicity, high activity against burn-wound bacterial pathogens, blocking bacterial invasion, inhibition of inflammation, reduced scarring, enhanced epithelialization and formation of granulation tissues, and so forth. Namazi et al. fabricated a carboxymethylcellulose hydrogel that incorporated MCM-41 mesoporous silica nanoparticles (MSN) nanocarriers, loaded with tetracycline and methylene blue. The MCNs helped control the hydrogel swelling and provided controlled drug release, potentiating the antimicrobial effects against *S. aureus*. These benefits suggested that the time intervals between changing the antimicrobial bandage could be elongated \[[@R276]\]. Zhao et al. also reported an electroactive injectable hydrogel wound dressing for cutaneous wounds with properties such as antibacterial activity, antioxidant, self-healing, improved hemostasis and adhesiveness. [Figure 6](#F6){ref-type="fig"} illustrates the synthesis process of these hydrogels \[[@R277]\].

Recently, a wound-dressing platform was developed based upon oxidized pectin-gelatin nano-hydrocolloids (OP-Gel). These were prepared by dip coating technique, consisting the entrapment of silver NPs (NS-OP-Gel) or ciprofloxacin (Cipro-OP-Gel) inside the hydrogel ([Figure 7-a](#F7){ref-type="fig"}). The results (compared to commercially available Bactigras® chlorhexidine dressing) indicated high antimicrobial activity, enhanced neovascularization, stimulated cell migration, better-organized deposition of collagen, and good hydrophilicity for both NS-OP-Gel and Cipro-OP-Gel dressings. The NS-OP-Gel showed enhanced antibacterial function (at very low loading of 3.75mg per cm^2^) and Cipro-Op-Gel (at 1% drug loading) against *E. coli* and *S. aureus.* NIH3T3 fibroblast proliferation was inhibited most by Bactigras® slightly by NS-OP-Gel andf not all by Cipro-OP-Gel. [Figure 7-b](#F7){ref-type="fig"} shows the microscopic images of full thickness wounds of C57BL/6J mice on day 21 after the burn injury. The histological analysis of the excised tissue at wound site is also shown in [figure 7-c](#F7){ref-type="fig"}. Healing rate was enhanced by NS-OP-Gel, while there were similar rates for Cipro-OP-Gel and Bactrigas® \[[@R278]\].

Microspheres can be also employed to prepare wound dressings. Romic et al. showed the ability of CS/Pluronic® F127 microspheres loaded with melatonin to serve as wound healing dressings A good sustained release of melatonin, showed an antibacterial effect against *S. aureus* and clinical isolates of MRSA, along with high biocompatibility with keratinocytes (e.g. HaCaT) and fibroblasts (e.g. BJ) \[[@R279]\].

Nanofibers have also been investigated for wound therapy as dressings or membranes, and so forth. In a recent study, N,N,N-trimethyl CS fibers were used as wound dressings and showed good antibacterial activity against *S. aureus* (\>99%) and *E. coli* (\>63%), while showing a lack of toxicity to mouse embryonic fibroblast cells at low concentrations. In-vivo tests revealed improved re-epithelialization and better wound contraction \[[@R280]\]. Elsewhere, electrospun SF nanofiber membranes were designed and loaded with an antimicrobial peptide immobilized via EDC/NHS and thiol-maleimide click chemistry conjugation. This platform illustrated a long-lasting antibacterial activity. Beneficial effects on monocytes, keratinocytes and fibroblasts were reported, such as enhanced proliferation and/or differentiation of various cells (HaCaT cells and NHDF cells) and improved cell-cell attachment, together with inhibition of the LPS-triggered expression of TNF-α from monocytes e.g. Raw264.7 cells \[[@R281]\]. Multifunctional core-shell NFs can be utilized for wound dressings \[[@R282]\]. Recently, Wei et al. used such structures to accelerate wound healing. They applied polycaprolactone (PCL) as a mechanically strong core and used collagen as a biocompatible shell. In this NF scaffold, vitamin A palmitate was encapsulated in the PCL core as a pharmaceutical to accelerate wound healing, and Ag-NPs as an antibacterial material was integrated in the collagen shell. The encapsulated Ag-NPs demonstrated antibacterial activity against S. *aureus*, and nearly 70% of loaded vitamin A palmitate was released after 6 days. In addition, L929 cells (mouse fibroblasts) attached well on the PCL-collagen core-shell NFs after 5 days \[[@R283]\].

Three-dimensional (3D) NFs scaffolds are considered to be a promising approach in tissue engineering to emulate ECM \[[@R284], [@R285]\]. In one study, Park et al. designed a 3D electrospun-based silk-fibroin NF scaffold using freeze drying, and salt-leaching followed by electrospinning with NaCl. Moreover, human skin keratinocytes (HaCAT) and fibroblasts (NIH 3T3) were co-cultured in 3D silk-fibroin NF scaffolds to mimic a bilayered skin structure *in vitro*. Their finding showed improved fibroblast proliferation in the internal layer of electrospun/NaCl based-scaffold compared to freeze dried and salt-leached 3D scaffolds. Better keratinocyte differentiation was demonstrated in the external layer of salt-leached 3D scaffolds than that prepared by freeze dried and electrospun with NaCl methods \[[@R286]\].

Self-assembled NFs produced from self-assembled peptides (SAP) can be employed to fabricate self-assembled hydrogels as scaffolds, applied for the proliferation and regeneration of skin cells in wound healing \[[@R287]\]. In one report, Bradshaw et al. generated hydrogel NF scaffolds from RADA16 (1% w/v) self-assembled peptide. They studied the effect of three peptides including RADA16, RADA16 containing a fibronectin motif (RADA16-GG-RGDS) and RADA16 containing a collagen type I motif (RADA16-GG-FPGERGVEGPGP) on the migration and expansion of immortalized human keratinocytes as well as mouse embryonic fibroblasts. Two glycine residues (GG) were also added to ensure the motif flexibility. RADA16-FPG effectively inhibited fibroblast proliferation and mildly suppressed keratinocyte expansion ([Figure 8](#F8){ref-type="fig"}), compared with RADA16 and RADA16-RGD (Arg-Gly-Asp) scaffolds, at 72 hours \[[@R288]\].

6.4 Smart stimulus-responsive NSs for burn wounds {#S34}
-------------------------------------------------

Stimuli-responsive smart materials are starting to open new horizons in nanomedicine \[[@R289]--[@R295]\], and their abilities are expected to potentiate development of effective therapies for burn wound injuries and infections. This aim is possible due to the ability of so-called "smart nanomaterials" to respond to cues in their microenvironment, so they can provide "on-demand" interaction with cells (e.g. gene expression only in specific cells and only when desired). Smart nanomaterials can control their own behavior and fate, resulting in improved signaling and treatment mechanisms in burn wounds and infections, and minimize side-effects. In addition, stimulus-responsive smart nanomaterials can provide on-demand and appropriately-controlled liberation of miscellaneous therapeutic agents \[[@R296]--[@R298]\].

Stimulus-responsive NSs in the form of 3D-scaffolds are able to undergo on-demand morphological deformation such as volumetric swelling in response to environmental changes e.g. changes in the cellular environment and in the surrounding medium. This could lead to improved healing of burns and chronic wounds. For example, You et al. hypothesized that local pH changes (e.g. when hypoxia occurs) could change the ability of a pH-dependent scaffold to transport vital molecules (e. g. oxygen, glucose and other nutrients), as well as affecting the local cell density growing on the scaffold. Here, acidic pH-induced swelling of dimethylaminoethyl methacrylate (DMAEMA)/ 2-hydroxyethyl methacrylate (HEMA) scaffolds enhanced the penetration of oxygen and increased cell infiltration, compared to non-pH sensitive scaffolds. Furthermore, other results showed improved formation of granulation tissue, increased expression of tissue-regenerating factors and pro-healing genes, more angiogenesis and better tissue remodeling were reported. Mechanical stretching of the scaffold was also suggested as a probable factor that could induce tissue regeneration ([Figure 9-a](#F9){ref-type="fig"}) \[[@R299]\]. In another study, a tannic acid (TA) loaded hydrogel designed by Voelcker et al. was employed in which carboxylated agarose was cross-linked with zinc ions to allow pH-dependent liberation of the cargo \[[@R300]\]. The results showed sustained TA release at acidic pH values along with significant swelling (with a highly enhanced compressive modulus of 0.947 MPa), and wioth insignificant release at alkaline and neutral pH values ([Figure 9-b and -c](#F9){ref-type="fig"}). No cytotoxicity was seen towards 3T3 fibroblasts, while good anti-bacterial and anti-inflammatory effects were observed (the latter due to TA-induced inhibition of NO generation in activated human macrophages). Grützner et al. \[[@R301]\] studied the effect of enzyme-sensitive antimicrobial nanoplatforms loaded with polyhexanide biguanide (cationic polymer) and octenidine (cationic surfactant) for prophylaxis against infection in cutaneous burns. The results showed time-dependent cellular uptake, along with no major effect on expression of cytokines and pro-inflammatory molecules by endothelial cells, insignificant cytotoxicity compared to solutions of antiseptic agents, and no inhibition of angiogenesis. Elsewhere, an antimicrobial enzyme-responsive antibiotic-loaded nanocarrier was reported that could respond to microbial drug-resistance enzymes such as penicillin G amidase and β-lactamase. ([Figure 9-d](#F9){ref-type="fig"}) shows enhanced wound healing, bacterial-selective delivery, high structural stability with modular design, and decreased side-effects using this system \[[@R302]\].

Temperature-responsive NSs have also been investigated for disinfection purposes. A smart-stimulus-responsive nanocarrier equipped with the thermo-sensitive moiety, poly-N-isopropylacrylamide, showed triggered release of bacteriophages targeted against specific bacterial infections. This innovative concept could be used for therapy of infected burns \[[@R303]\].

Ultrasound irradiation has been used to activate NPs in infected wounds. Osumi et al used ultrasound (1.0 MHz, intensity of 0.4 W cm^−2^) to activate TiO~2~ NPs, which produced ROS. They claimed that ROS at physiological level could improve cell response and angiesis, whereas higher levels could carry out disinfection; therefore enhancing healing of the infected sites. Ultrasound therapy could enhance the penetration of NP into the tissues to treat deeper infected sites. [Figure 10](#F10){ref-type="fig"} shows (a) images of the infected wounds treated with or without using ultrasound-activated TiO~2~ NPs, (b) curves illustrating relative wound size percentage calculated compared to the initial wound size \[[@R304]\].

The family of matrix metallo-proteinase (MMP) enzymes, which mediate the balance between the generation and degradation of ECM, has an inevitable function in the healing of wounds, as well as in the remodeling of epidermal layers. In one study Kim et al. \[[@R306]\] showed the MMP2-responsiveness of a 4-arm PEG-conjugated siRNA molecule that underwent clustering leading to formation of nanoscale particles containing MMP-cleavable linkers. These NPs were resistant to RNase hydrolysis (compared with free siRNA) and could mediate gene transfection, leading to enhanced wound healing. There was low cellular uptake of the clusters in the absence of MMP, while in cells that expressed MMP, the clusters dissociated and endocytosis occurred. Wound closure was enhanced, while decreased MMP2 expression was caused by gene silencing together with higher cytokeratin expression in the healed wound.

Elsewhere, the use of a nanofibrous matrix containing a MMP-cleavable linker and decorated with siRNA encoding the silencing of the MMP2-gene was tested in a wound healing model \[[@R307]\]. In another study, MMP secretion was shown to have a key role in re-epithelialization and acceleration of healing as well as extracellular-induced regulation of kinase signaling in the wound healing process \[[@R308]\]. In a recent study elevated lysozyme activity was exploited as a biomarker of infection in order to activate a stimulus-responsive antimicrobial platform. N-acetyl chitosan (degree of N-acetylation: 40%) was hydrolyzed by lysozyme in artificial wound fluid to give N-acetylated chito oligosaccharides (COS). These COS were shown to serve as substrates for added cellobiose dehydrogenase (CDH) leading to the production of 1 mM hydrogen peroxide (H~2~O~2~) after 24 h incubation. This was a sufficient concentration to induce an antimicrobial effect against *S*. aureus *and E. coli* ([Figure 10-c](#F10){ref-type="fig"}) \[[@R305]\].

6.5 Photothermal and photodynamic therapy for antimicrobial activity and wound healing {#S35}
--------------------------------------------------------------------------------------

NPs can be activated by incident light taking advantage of either photothermal or photodynamic therapy-based mechanisms, and can kill microbial cells in wound sites and improve wound healing. The principle of photothermal therapy (PTT) is conversion of light to a localized heating effect due to photo-excitation of metallic NPs (AuNPs) or inorganic NPs (graphene, magnetic NPs. MoS~2~) \[[@R309]--[@R313]\]. Various materials can be utilized to obtain the PTT-activated antibacterial effect such as photothermal NPs or agents such as molybdenum disulfide (MoS~2~), GO, and polypyrrole NPs (PPy) \[[@R127], [@R314], [@R315]\].

In one study, a 1064 nm NIR laser was used for surface photothermal activation of GO, which led to highly efficacious antibacterial activity in a non-invasive and inexpensive approach. This nanoplatform was applied against pathogens including *P. aeruginosa* and *S. aureus* \[[@R127]\]. Elsewhere, an NIR-activated nanoplatform was designed for combination therapy, comprised of a photothermal agent (PPy) and an antibiotic (Van), both incorporated into hollow microspheres made of PLGA. When administered into the wound site, NIR light photothermally triggered both localized hyperthermia and antibiotic drug release, resulting in activation of a synergistic antibacterial activity \[[@R314]\].

Recently, PEG-functionalized MoS~2~ nanoparticles were synthesized, and exploited for simultaneous NIR-induced photothermal and peroxidase-like catalytic activity. [Figure 11-a](#F11){ref-type="fig"} shows the mechanism of action of this multifunctional nanosystem. Peroxidase activity allows conversion of H~2~O~2~ to hydroxyl radical (•OH) that have strong antibacterial activity. The synergistic effect of the catalysis and 808nm-irradiation-triggered PTT of PEG-MoS~2~ NPs led to effective eradication of Gram-negative ampicillin resistant *E. coli* and Gram-positive endospore-forming *B. subtilis* ([Figure 11-b](#F11){ref-type="fig"}) in wounds. The photothermal effect was also reported to cause glutathione (GSH) oxidation, inducing even more effective bacterial death ([Figure 11-c](#F11){ref-type="fig"}). \[[@R315]\].

The concept of PDT is that photon absorption can excite the ground state of a photosensitizing agent (incorporated for instance in NPs) to a long-lived triplet state, leading to an energy transfer reaction with molecular oxygen, thus generating singlet oxygen as reactive species. Electron transfer reactions can also take place producing other ROS e.g. superoxide radicals, free hydroxyl radicals and hydrogen peroxide \[[@R317], [@R318]\]. PDT can be used to kill various microorganisms (bacteria, viruses, yeasts, fungi, parasites and cancer cells) \[[@R319], [@R320]\]. PDT has been reported to treat dermatological diseases and infections \[[@R321]\]. Two recent studies suggested that PDT could be used as an effective antimicrobial method for burn infections \[[@R322], [@R323]\].

Nafee et al. reported a polymeric nanoplatform encapsulating the naturally-occurring photosensitizer, hypericin, as an antibiotic-free agent for PDT-based antimicrobial therapy. They tested clinical isolates of MRSA biofilms and planktonic cells. Excitation of the photoactivatable 45 nm-diameter NPs generatied ROS and gave a higher antibacterial effect against biofilms than planktonic cells, and in-vivo tests showed accelerated healing, and improved epithelialization, keratinization and generation of collagen fibers \[[@R128]\]. In a recent study, poly-cationic poly-lysine was conjugated to chlorin p6 (photosensitizer) was reported for topical PDT of mice with wounds infected with *P. aeruginosa*. To this end, hyper-inflammatory response of bacteria was investigated. [Figure 11](#F11){ref-type="fig"} shows histological analysis including unwounded tissue ([Figure 11-d (i)](#F11){ref-type="fig"}) and wounded tissue with different treatments ([Figure 11-d (ii--v)](#F11){ref-type="fig"}). Complete re-epithelialization, and no necrotic or inflammatory areas were reported in the uninfected wounds, while the non-treated infected wound and infected wound treated only with drug-conjugate (no light) and slow healing, and disorganized collagen (due to excessive production of TNF-α). Light irradiation with doses of 60 and 120 J/cm^2^ onto the drug-treated infected wound area decreased the bacterial load, led to 5-days earlier healing, and the wounds showed parallel collagen fibers, no edema, shortened inflammatory phase, fewer inflammatory cells, and faster re-epithelialization. Significant reductions in TNF-α and cytokines IL-6 were reported at 96h post-treatment. Culture supernatants showed decreased bacterial protease activity (\~ 50%) indicative of inactivation of extracellular virulence factors \[[@R316]\].

6.6 NS-based cell therapy for wound healing {#S36}
-------------------------------------------

Stem cell therapy is an example of advanced tissue-engineering techniques, which can be potentiated by different nanotechnology-based platforms, such as 3D cell-scaffold biostructures and hydrogels to improve wound healing. Kamp et al. \[[@R324]\] interrogated the capability of MSCs for therapy of chronic wounds or burns, that were combined with an MSC chemoattractant, hepatocyte growth factor (HGF) loaded in collagen and silk fibroin scaffolds. Here, the release of active HGF from the scaffolds was indicated to induce direct cell migration, leading to endogenous recruitment of MSCs from the local environment in the scaffolds

In one study Chung et al. \[[@R325]\] developed an engineered 3D-scaffold made of PEGylated fibrin gel that was assessed for delivery of ASCs into the burn injury site. ASC delivery led to enhanced vascularization and more cells expressing the mannose receptor, as well as early recruitment of mononuclear cells with improved granulation tissue generation. No negative influence on connective tissue extension or wound closure kinetics was reported. Elsewhere, Burmeister et al. \[[@R326]\] reported a platform comprised of ASCs and PEG-fibrin hydrogels as a scaffold, which was tested in a porcine model of debrided burn wounds. The delivery of ASCs into the wound site using the scaffold produced improved skin angiogenesis (in a dose-related manner) and better wound healing. Furthermore, the PEG-fibrin scaffolds could inhibit skin contraction after the meshing of autografts. In another study, Bio-NSs based on BC and MNPs were investigated an as effective tool for healing of chronic wounds. The morphology, viability and expansion of human ASCs, and the low cell toxicity of the scaffolds indicated BC-MNPs as a smart NS for chronic wound healing \[[@R269]\].

6.7 NSs for growth factor delivery {#S37}
----------------------------------

Growth factors can be exogenously delivered into wounds so as to activate healing process. Basic fibroblast growth factors (bFGFs) can induce fibroblasts to proliferate and migrate, endothelial cells to proliferate, as well to carry out angiogenesis. In research conducted by Butko et al. \[[@R327]\] bFGF was loaded into NPs made from succinylated-CS. The results showed a burst release profile, while co-encapsulation of bFGF together with heparin led to the maximum release (18%).

In another research \[[@R328]\], a hydrogel-sheet based on thiolated heparin attached to PEG and loaded with human EGF was used for wound healing ([Figure 12-a](#F12){ref-type="fig"}). The profile showed a sustained release pattern. Applying the hydrogel sheet onto deep wounds on the back of mice improved the wound closure rate ([Figure 12-b and -c](#F12){ref-type="fig"}), while stimulating granulation tissue formation and better epithelialization and capillary formation.

6.8 NSs for gene delivery {#S38}
-------------------------

Gene therapy is regarded as a novel and powerful technique for treatment of wounds and skin damages. In one study, Du et al. reported the rapid closure of burn wounds and improved healing stimulated by the gene transfection of DNA coding for hypoxia inducible factor-1 (HIF-1α) to induce angiogenesis, integrated with intravenous infusion of HIF-1-activated angiogenic cells cultured with the hydroxylase inhibitor, dimethyloxalylglycine \[[@R329]\]. Moreover, because highly efficient delivery of genes into cells and tissues is regarded as the path to success for gene therapy, NSs can function as a non-viral platform for efficacious delivery of genes. For example in one study, gene-silencing using Flightless I (Flii) siRNA loaded into CS-coated porous silicon NPs was used in a cutaneous wound site for down-regulation of Flii (a cytoskeletal actin remodelling protein, which negatively affects wound healing). The addition of this nanoplatform to keratinocytes caused a reduction in Flii gene-expression and lower Flii protein production. Cell migration and proliferation were enhanced, and were followed by better healing in acute excisional wounds \[[@R330]\]. Peng et al. prepared pDNA-VEGF165/β-cyclodextrin- linked polyethylenimine (CYD-PEI) polyplex NPs embedded in a gelatin/β -TCP scaffold. This 3D transfection platform was utilized for manipulation of ESCs in wound site. The results indicated prolonged VEGF expression in the ESCs and topical administration led to angiogenesis, accelerated re-epithelialization, and increased dermal collagen and hair follicles \[[@R331]\].

6.9 Combination therapies for wound healing {#S39}
-------------------------------------------

Various approaches have been developed for wound treatment, and recently it has been realized that these approaches will probably need to be used in combination if a substantial advance in potentiating the healing process is to be achieved. In recent investigations, different combination wound therapies have been reported including combinations of already approved clinical modalities, negative-pressure wound therapy combined with pulsed radiofrequency energy \[[@R332]\]; and a combination of photobiomodulation with antidiabetic medication \[[@R333]\]. The combination of topical negative pressure and silver-impregnated foam has also shown a synergistic inactivation against bacterial biofilms in the wound site \[[@R334]\].

Integration of stem cells with other potent therapeutics have demonstrated significant effects such as improved wound closure and angiogenesis, enhanced cell migration and proliferation, as well as negligible toxicity or inflammation in wounds \[[@R335]--[@R340]\]. Such investigations have designed stem cell-integrated combination therapies, which can also possibly be considered for burn wounds.

External stimuli have been also utilized in combination wound treatments. Some examples are the combined use of pulsed wave low-level laser therapy and stem cells \[[@R340]\]; the combined administration of LLLT/light-emitting diode (LED) \[[@R341]\]; and the concurrent exploitation of therapeutic high-frequency ultrasound and microcurrent electrical stimulation \[[@R342]\].

The introduction of nanotechnology to wound therapy has been investigated via diverse routes. Some recent examples are: a complex of different GF combinations and hyaluronic acid (HA) loaded into liposomes \[[@R343]\]; and the synchronous use of an ointment containing therapeutic NP and wound healing medicines, which have been reported to have beneficial results for skin wound healing \[[@R344]\]. In another investigation, the targeting ability of magnetic NPs was combined with an angiogenic gene therapy using a gene transfer technique to improve angiogenesis and wound healing \[[@R345]\]. In another study on wound treatment, a "lipoproteoplex" (i.e. liposome and protein hybrid) NP preparation was developed for efficient siRNA delivery as a gene therapy approach for wound therapy \[[@R346]\]. Hydrogels have also been attractive components in combination therapies; some recent examples are as follows: combination of LLLT and policaju (derived from *Anacardium occidentale* L gum)/chitosan hybrid hydrogels \[[@R347]\]; the integration of hydrogels and stem cells \[[@R337]\], the combination of hydrogels and platelet-rich plasma \[[@R348], [@R349]\], and so forth.

Several combination therapies aimed at wound healing have been studied in different phases of clinical trials, such as a clinical trial recently conducted to investigate the effect of simultaneously using gelatin sheet and platelet-rich plasma release \[[@R350]\].

6.10 New technologies in tissue regeneration and wound healing {#S40}
--------------------------------------------------------------

In the era of translational medicine with a range of bench-to-bedside efforts being conducted to transfer preclinical studies to clinical products, well-designed efforts are absolutely required in order to eliminate previous deficiencies and shortcomings, especially in the fabrication methods of therapeutic products, such as complicated design methods and the high-cost of processes and materials, but also to produce user-friendly and low cost technologies. In this regard, some innovative approaches have recently been introduced in tissue engineering. Among such advances, nano-scale architectured substrates, cell-imprinted substrates and 3D-printed scaffolds are of particular interest. Furthermore, from a biotechnology aspect, some revolutionary techniques have emerged, including CRISPR-Cas9 gene editing, which will change the future of genetic engineering, tissue regeneration and may lead to new therapies for serious diseases such as cancer, HIV, and genetic defects. Hence, these newly emerged technologies are briefly discussed below:

### 6.10.1 Nanoscale architectured and textured substrates {#S41}

Cells live in an environment with features on both the micrometer and nanometer scales where they govern various functional behaviors. Nanoscale-architectured structures employed in implantable biomaterials can be used to mimic bio-physicochemical environments and cellular niches to control cellular behavior \[[@R351]\]. More recently, advances in nanotechnology have provided new methods to create substrates equipped with surface nanotopography, emulating ECM architecture or providing suitable cell microenvironments. Nanotopography or nano-architectures have been shown to have a vital function in inducing or modulating cellular activity, motility, viability, morphology, adhesion, differentiation, expansion and migration \[[@R352], [@R353]\]. In the body environment, stem cells of various lineages e.g. human embryonic stem cells (hESCs) and hMSCs have the potential to differentiate into diverse cell types and can be applied in regeneration and tissue engineering. Stem cells can be influenced by employing tailored biochemical micro- and nano-architectures consisting of both solid materials and soluble molecules. The use of nano-topographies and nano-architectures as advanced implantable platforms that mimic the biophysical properties of the cellular microenvironment can accurately guide stem cells in their self-renewal, proliferation and differentiation processes \[[@R354]--[@R356]\]. In the recent literature, a wide range of nano-topographic geometries and arrays including nanopits, nanoposts, nanogratings, pillars, grooves, ridges, nanotubes, nanopores, nanowires, and so forth, have all been reported to have tissue engineering applications \[[@R357]--[@R362]\].

The use of nano-architectured substrates that incorporate stem cells in cell-based therapy approaches is of high interest. Recently, the effect of controllable biophysical signals on the mechanosensitivity of cells has gained substantial attention. In one study, Chen et al. designed patterns with controllable nano-roughness on glass surfaces as a culture substrate for hESCs and NIH/3T3 fibroblasts. Their finding revealed that the nano-topography created a potent regulatory environment for hESC responses related to cell signaling and functions such as cell morphology, adhesion, self-renewal and proliferation, which were cell-type specific. Here, the topological sensing ability of hESCs resulted in feedback regulation, associated with the mechanosensory integrin-mediated adhesion to the cell-matrix, E-cadherin, and myosin II \[[@R363]\]. In a similar study, Yim et al. observed that the nano-topography and stiffness of substrates could modulate the behavior of hMSCs by altering the formation of activated integrin clusters and assembly of focal adhesion complexes. This, consequently, regulated the organization of the cell cytoskeleton of hMSCs cultured on a substrate with 350 nm grating nano-topographies on the surface of tissue-culture grade polystyrene and polydimethylsiloxane (PDMS) substrates. Here, by employing the nano-topographies, the expression of various integrin molecules including alpha, alpha 2, alpha V, beta2, beta 3 and beta 4 was decreased in comparison with the control group (i.e. non-patterned substrates). Moreover, the mechanical properties (e.g. Young\'s modulus and apparent viscosity) and expression of cytoskeleton and focal adhesion components were also changed on the patterned substrates. The grating nano-topography induced alignment of the actin cytoskeleton of the elongated hMSCs whereas the non-patterned substrate led to a dense and random spreading of the actin cytoskeleton network \[[@R364]\].

The differentiation of fibroblasts into myofibroblasts is an important stage in wound healing because of the important role of myofibroblasts in restoring skin homeostasis and modulating tissue physiology in the wound healing process \[[@R365], [@R366]\]. Keratinocyte behaviors can be influenced by modification of nanoscale topographies, which may cause improvements in wound healing \[[@R367], [@R368]\]. Parkinson et al. in a study, evaluated the effect of nano-topography on keratinocytes including their morphology, proliferation and migration for treatment of burn wounds. Herein, nanoporous anodic aluminum oxide (AAO) membranes were employed with a pore size of 300 nm, which increased keratinocyte expansion and migration and could cover a partial thickness burn wound. A burn injury dressing incorporating a nano-topographical AAO membrane enhanced skin healing with a significantly reduction in tissue granulation and maturation of epidermal layers, compared with a control group \[[@R369]\]. In a similar study, Pot et al. reported nano-topography could regulate keratocytes, fibroblasts and myofibroblasts, which have a major role in corneal wound healing. These cells were seeded onto planar polyurethane surfaces. After 24 h, the keratocytes, fibroblasts and myofibroblasts were stained and imaged for cell shape analysis as well as for studying migration rates. Here, the elongation of keratocytes, fibroblasts and myofibroblasts were reported to be more than 1000 nm on a pitch (i.e. groove + ridge) patterned surfaces where cells responded to topographic features that had a lower limit of size with a transition zone of 800 to 1200-nm pitch size. Moreover, using this nano-topography, while keratocytes remained motionless, the migration of fibroblasts as well as myofibroblasts toward surface ridges larger than 1 µm was also reported; however, directional guidance on submicron/nano-topographic or planar surfaces was lacking \[[@R370]\].

### 6.10.2 Cell-imprinted substrates {#S42}

Cell-imprinted biomaterials are able to mimic the natural environment of stem cells, and induce stem cell differentiation and expansion for wound healing and artificial tissue applications \[[@R371], [@R372]\]. In this regard, various cell types and morphologies can be imprinted to design a proper cell niche micro-/nano-environment. The cost-effectiveness and high efficiency of this approach is likely to have many advantages in tissue engineering and regeneration as well as wound therapies, using various cell casting processes on surfaces \[[@R373]\]. In one study, cell-imprinted substrates were reported to function as an artificial NS for skin repair. Herein, PDMS casting based-cell-imprinted micro-/nano-environments were created using human keratinocyte patterned templates. The keratinocyte-cell-imprinted biomimetic substrates could mimic the surface morphology of the cell membrane, which created a suitable micro-/nano-environment for topographical-induced cell differentiation. Moreover, seeded ASCs on the cell-imprinted surfaces were stimulated to adopt keratinocyte morphology and properties. Molecular dynamics simulation of the stem cell nucleus interestingly revealed that changing the shape of stem cells into that resembling mature cells could affect the deformation of the nucleus and subsequent gene expression. The results demonstrated the cell-imprinted substrate could be utilized as an effective strategy to differentiate stem cells to skin cells for wound healing \[[@R374]\]. More recently, a similar research reported cell-imprinted surfaces as a smart nano-environment, constructed by utilizing templates so that different cell types, including chondrocytes, tenocytes and semifibroblasts had potentials to differentiate, re-differentiate and trans-differentiate from the seeded ASCs. Moreover, immunofluorescent staining of proteins such as collagen type II in chondrocytes revealed that ASCs, semifibroblasts and tenocytes were able to attain the chondrocyte phenotype after 2 weeks of being implanted on chondrocyte-imprinted substrates. These results indicated that cell-Imprinted substrates could be applied in skin regeneration and cell-based therapy \[[@R375]\].

### 6.10.3 3D bio-printed scaffolds {#S43}

3D printing is an advanced technology that has been progressing rapidly, and demonstrating revolutionary effects in biomedical research and therapies. In 3D printing, complex biomolecules and even living components such as (stem) cells, proteins (e.g. fibrin, collagen, growth factors, etc.), and therapeutic molecules can be precisely patterned and assembled through layer-by-layer deposition on scaffolds e.g. hydrogels, with the aid of computer-aided designs and manufacturing (e.g. CAD and CAM) \[[@R373]\]. This technology can be used in several health care applications, including tissue regeneration; prosthetics fabrication, implant creation, anatomical model fabrication and drug delivery investigations \[[@R376], [@R377]\]. The potential of 3D printing and its ability to construct complex and elaborate patterns and architectures can be utilized in the study of wound healing therapies to manufacture 3D-scaffolds, dressings, etc. or to create powerful platforms as skin models to investigate and find treatments for skin diseases such as burn wounds ([Figure 13](#F13){ref-type="fig"}). Bio-printing based formation of cell-matrix components has been reported for the regeneration of skin tissue and formation of stem cell-scaffold complexes to thoroughly cover the full-thickness skin damage in burn wounds \[[@R373]\]. As an example of recent pioneering studies, Lee et al. produced eight collagen layers as human-like skin using a 3D printing platform. The structure of the 3D printed platform consisted of implanted cells within a multi-layered collagen construction on poly-d-lysine-coated glass petri dishes previously nebulized by sodium bicarbonate steam. The eight layers of collagen consisted of six collagen layers sandwiching three layers of fibroblasts and two additional collagen layers that included keratinocytes \[[@R378]\].

As 3D-printable platforms have been dramatically progressing in recent years, unprecedented concepts have been also introduced to this area such as \"4D-printing\". In this regard, the introduction of smart materials into 3D-printable platforms has been called as \"4D-printing\", which means the shape, performance, functionality and properties of printed smart materials can be altered over time (as the 4^th^ dimension) and in response to different stimuli. 4D-printed structures can be designed to be self-assembled, multi-functional, self-repairable, etc. In this regard, 4D-bioprintable platforms will likely become an important area of research in tissue regeneration and engineering, particularly for printable smart scaffolds, skin regeneration and artificial skin, with applications in (burn) wound healing and regeneration \[[@R379], [@R380]\]. From the bio-inspired aspect, 4D-bio-pintable platforms are printed objects that can show smart stimuli-responsive behavior when for instance, external stimuli are applied, or when cell-fusion or post-printing self-assembly are employed \[[@R381]\].

### 6.10.4 CRISPR-Cas9: new gene editing tool for reprogramming of stem cells {#S44}

Gene editing through the clustered regularly interspaced palindromic repeats (CRISPR)-Cas system has been introduced for the modification of the genome in many microorganisms and eukaryotic cells \[[@R382]\]. Originally discovered as a form of bacterial immunity to viruses, type 2 known as CRISPR-Cas9 system is a simple and efficient tool employed for manipulation of heterogenous and endogenous gene expression. This breakthrough approach can be applied for somatic and embryonic gene therapy, genomic screening and the generation of animal models that have been exploited in all biomedical-related researches, ranges from basic research to gene therapy \[[@R383], [@R384]\]. CRISPR/Cas9 system can be applied to reprogram primary fibroblasts so as to produce iPSCs. iPSCs themselves have the potential to differentiate into other cell types such as keratinocytes and MSCs, which are the most important cells for wound regeneration \[[@R385], [@R386]\]. More recently, a CRISPR-Cas system was reported, which could be applied in gene therapy for skin diseases and wound healing. Herein, the designed gene therapy system enhanced skin growth factors expression such as EGF, TGF-β, PDGF and FGF \[[@R387]\]. Hence, CRISPR-Cas9 gene editing technology can be a highly potent tool in cell and tissue engineering as well as regenerative medicine. In addition, it suggests new horizons in wound healing and infection prevention, which requires more research to be conducted to fully realize the potential. [Figure 14](#F14){ref-type="fig"} illustrates the concept of exploiting the gene editing tool, CRISPR-Cas, for reprogramming of stem cells (e.g. iPSCs), where reprogrammed (i.e. differentiated) cells can be integrated in fabricated 3D-scaffolds, for wound healing applications.

7. Animal models for burn wounds {#S45}
================================

Animal models of burn wounds are widely used in the laboratory to evaluate different drugs and treatments that are being developed for treatment of human burn victims \[[@R388]\].

In wound therapy research, regarding various wound models, different aspects should be considered including incision or excision models, acute, chronic or diabetic wounds, administration methods for therapies (e.g. topically, intravenously, intradermally, and spray), in-vitro models (e.g. EpiDermFT as an epidermal full-thickness model, and human/mouse fibroblast and keratinocyte models as popular models), in-vivo models (e.g. rat and mouse that are cost-effective and user-friendly, as well as pig and rabbit), and so forth \[[@R154]\].

Burn wounds are usually created on the shaved backs of animal models such as mice, rats, rabbits and pigs, with a range from 5% to 30% TBSA for 3 to 30 seconds to produce partial to full thickness thermal damage. As an advantage, anatomically and physiologically the skin structure of the guinea pig is more analogous to human skin compared with mouse and rat. The epidermal thickness of pig is 30 to 140 µm similar to the human epidermal thickness which is 50 to 120 µm \[[@R389], [@R390]\]. Thus guinea pig burn models are better able to emulate human thermal wounds. However, mice and rats are less expensive than guinea pigs. Studies have revealed that inoculating infectious microorganisms topically is more clinically relevant than injecting them under the burn wound \[[@R391]\]. Investigations have also shown that acute infections can be induced in animal models e.g. mouse, rat and pig by invasive microorganisms such as *P. aeruginosa*, whereas chronic infections can be created using less virulent microorganisms such as *S. aureus* \[[@R7], [@R392]\]. Here we briefly discuss important animal models for burn wounds, which are classified as: gas flame burn model, burning ethanol bath burn model, pre-heated single metal plate/bar boiling or hot water burn models, and pre-heated double brass block burn model \[[@R391]\].

7.1 Gas flame burn model {#S46}
------------------------

### Katakura burn model {#S47}

In this model, a 2.5 × 3.5 cm window equipped template is placed on the shaved back of mice, and subsequently, the exposed site on the skin is heated for 9 second using gas flame. This flame-induced burn model can create a third degree burn with a nearly 15% TBSA on 26 g SCID-bg mice. Subsequently, gas flame burned immune-deficient mice are inculcated with a 2 × 10^3^CFU MRSA and various numbers of CFU *E. faecalis* to test the influence of an antimicrobial agent on antibiotic-resistant burn infections \[[@R393]\].

7.2 Burning ethanol bath burn model {#S48}
-----------------------------------

### Stieritz-Holder burn model {#S49}

These authors applied an ethanol bath to make a burn wound animal model. In this model, anesthetized and back-shaved female BALB/c mice weighing 22--24 g are used. To generate a nearly 30% of TBSA, back-shaved mice are exposed to an asbestos sheet containing a window, firmly pressed on the back. Subsequently, ethanol is evenly sprayed on the region specified by the window, and then ignited and allowed to burn for 10 sec. The bacterial infection models are created via inoculating 100 CFU of *P. aeruginosa* and *K. pneumoniae* into the burned subcutaneous area. Here, the infections can rapidly lead to death depending on the virulence of the bacterial strain chosen. This model has been employed to investigate the antibacterial function of polyclonal immunoglobulin antibodies for burn wound healing \[[@R391], [@R394]\].

7.3 Pre-heated single metal plate/bar burn models {#S50}
-------------------------------------------------

### Tavares burn model {#S51}

In this model, a pre-heated aluminum rod (51 g in weight and 10 mm in diameter) is utilized. To make a second degree burn wound, it is heated to about 98 to 100°C for 10 min. Subsequently, the heated aluminum rod is pressed on the shaved back of male rats for 15 sec. Every seven-days for 4 weeks, the anesthetized burned animal is evaluated for bleeding and infection. After 4 weeks, re-epithelialization cis usually completed through fibroblast expansion and new collagen synthesis \[[@R395]\].

### Orenstein burn model {#S52}

In this model, to create a third degree burn, a pre-heated 1 × 1 × 3 cm plate is used, with a 20 cm handle. The temperature of the copper plate is increased to 150°C where the plate is pressed on the back-shaved guinea pigs for 10 second. The burned area is inoculated after 15 min by 1mL suspension containing 10^8^ *S. aureus*. This model can be employed for the investigation of prevention and treatment of infected burns \[[@R396]\].

7.4 Boiling or hot water burn models {#S53}
------------------------------------

### Suzuki burn models {#S54}

In this model, male Wistar rats weighing 450--550 g are used and their skin is brought into contact with a glass chamber device through which water circulates for 1 min at 35--60°C over a seven-day period. The important variable is how firmly the device is pressed onto the skin (a common applied pressure is 10 g/cm^2^). This model benefits from the ability to vary exposure time and temperature \[[@R391], [@R397]\].

### Bahar burn model {#S55}

This burn model involves the application of a 2.5 cm^2^ thick piece of absorbent lint cloth submerged in boiling water. This cloth is then applied to the back of male Wistar rats weighing 250--300 g for varying times (2 or 10 seconds) \[[@R398]\].

### Bjornson burn model {#S56}

Here, female or male guinea pigs are utilized weighing 300--350 g. as a burn model. In this model, 60 cm^2^ area is submerged in water at 99°C for 13 second to make an about 15% TBSA. To create second thermal wound, after 1 h, the guinea pigs are again exposed in the template. Subsequently, the animals are inoculated with 5 × 10^5^CFU of *P. aeruginosa, S. aureus and C. albicans* under the burn area \[[@R399]\].

### Mason and Walker burn model {#S57}

These workers developed the first animal burn model in rats using boiling water, which is a standard boiling water burn model used in diverse investigations. In this model, a template is employed in the form of a thin metal half-cylinder that fits over the back of the rat. It has a hole of calculated dimensions in the central region of the half-cylinder. The size of the hole is determined to correspond with the size of the burn in the rat. The animal is anesthetized, then shaved on the back, followed by placing supine in the template. The exposed region is submerged into boiling water. To create a partial thickness (as 2^nd^ degree) and full-thickness (as 3^rd^ degree) burn model, back-shaved rats are exposed 3 and 10 seconds to boiling water, respectively. The upper restriction on wound burn size, permitting by Mason and Walker model is about 30% of TBSA. This model has been broadly employed in studies conducted on the suppression and therapy of burn wound infections, for example: bacterial translocation, testing various antimicrobial agents, gene therapy, wound dressing for inhibiting burn infections such as fungal (e.g. candidiasis) infections \[[@R391], [@R400]\].

7.5 Pre-heated double brass blocks burned models {#S58}
------------------------------------------------

### Kaufman burn model {#S59}

In this model, a cylindrical aluminum rod is utilized weighing at least 500 g, with diameter and length of the handle of 3.78 cm and 24 cm, respectively. The heating of the equipment is done while submerged in water for 120 minute, and then to create a deep partial skin thickness thermal wound at 75°C on shaved back of an anesthetized guinea-pig. The model can be applied to investigate epithelialization, contraction and scar formation of burn wounds \[[@R401]\]

### Stevens burn model {#S60}

This model uses two pre-heated brass blocks applied to the back of shaved mice for between 3 and 10 seconds depending on the depth of burn required. In this model, pre-heated double brass blocks (heated to 92--95°C) are placed onto either side of a raised skin fold on the back of the shaved mice for between 5 seconds depending on the depth of burn required, resulting in a 1.8 cm^2^ burned area being created with nearly 5% TBSA (as an example see [Figure 15](#F15){ref-type="fig"}). Subsequently, to generate a bacterial infection model, various numbers of *P. aeruginosa* CFU are inoculated onto the burned region or else are intradermally injected into the eschars. Bacteria can be recovered from the unburned muscle by 1 day for some bacteria. In this burn model, survival at 10 d has been reported to be 60% with *P. aeruginosa* infection \[[@R391], [@R402]\].

8. Recent clinical trial evaluations for wound healing {#S61}
======================================================

An essential step in using the various wound healing approaches discussed in the above-mentioned sections, is their translation into clinical applications and bench-to-bedside evaluation. In this regard, in this section, some of recent clinical trials in different stages of completion are summarized.

Essentially, clinical trials to understand the efficacy of (stem) cell therapy on the healing process of burn wounds are still needed so as to confirm their efficacy and wound-healing properties. In April 2017, Cytori Therapeutics Inc. obtained FDA approval for a pilot clinical trial of their product \"Cytori Cell TherapyTM\" using for thermal-burn injured patients. Here, the safety and feasibility of the product along with standard care for patients with 20% to 50% TBSA injuries was assessed \[[@R403]\]. In March 2017, a Phase I clinical trial in 2nd degree burn wound patients with less than 20% TBSA was verified to be conducted by University of Miami. The purpose of this investigation was to evaluate the safety of allogeneic MSC based treatment, and then to find the maximum safe dose to be used in the Phase II of this study \[[@R404]\].

Among currently used approaches for wound therapy, skin allografts have been suggested for dermo-protection and enhancing re-epithelialization in burn injuries \[[@R405]\].

The wound closure effect of "nitrosating substances" e.g. nitroso-thiols or RSNOs have been suggested due to their inflammation modulation, cytokine generation and vascular improvement functions. Employing nanotechnology can enhance the effect of such products. For example, recently an S-nitroso-N-acetyl cysteine containing hydrogel-based NP platform (NAC-SNO-np) was developed, with encouraging results in translational and bench-to-bedside studies. This nanoplatform could release NO in a timely manner, besides facilitating nitrosation. NAC-SNO-np also has been licensed by the company Nano Biomed Inc.\[[@R406], [@R407]\]. In another approach in 2007, Phase I and II clinical trials were designed and funded by National Institute of Health (NIH) to support filing with the FDA and marketing potential of a NO-generating topical gel for burn wound healing \[[@R408]\].

Ag NPs provide great promise in clinical applications of wound healing therapies. This is due to their intrinsic antimicrobial activity along with anti-inflammatory and wound healing effects resulting in scar reduction, suppression of local and systemic inflammation, modulation of cytokine levels, increasing wound closure via proliferation and migration of keratinocytes, and enhancing wound contraction via myoblast generation by fibroblast differentiation. Furthermore, the effect of Ag NPs as a UV and radio-therapy sensitizing agent and their effect on the immune system can be also considered \[[@R409]\].

Growth factors can influence wound healing, and clinical evaluation of their exogeneous application is required. PDGF, a growth factor and cytokine, can facilitate the transition from a chronic wound to short-term healing by stimulation of granulation tissue formation, and has been tested in clinical trials \[[@R405]\]. Delivery of PDGF as a topical agent to burn wounds may be achieved by nano-platform approaches. In 2010, a clinical study was reported to evaluate healing of second degree burn wounds using the growth factor, rhEGF. In this study, 80 elderly patients were studied from 2003 to 2008, and the results indicated that rhEGF enhanced burn wound healing \[[@R410]\]. In a recent first-in-man clinical trial, a collagen/gelatin scaffold was developed capable of sustained release of FGFs. The results of this clinical trial indicated the efficacy and safety of the scaffold applied on patients \[[@R411]\].

A phase I clinical trial carried out by Stanford University Medical Center (CA, USA) used a skin-based gene therapy for wound healing, and was hailed as the first safe and effective skin-based gene therapy. This study aimed at grafting genetically altered skin onto chronic wounds of epidermolysis bullosa patients \[[@R412]\].

In 2012, a randomized controlled trial was carried out where the analgesia effect of a combined donor compound that could release nitrous oxide (N~2~O)/oxygen was investigated to reduce pain associated with changing burn dressings \[[@R413]\].

In an recently conducted phase 1 clinical trial, the combination of high-voltage, pulsed-current electric therapy and silver-collagen dressing were shown to be efficacious for chronic full-thickness wounds \[[@R414]\].

In addition to the aforementioned case studies, the literature also contains examples, where the effects of keratinocytes and stem cells, pirfenidone NPs, hyperbaric oxygen, opioids, and so forth, on burn wound healing have been explored \[[@R415]\].

9. Concluding remarks and perspectives {#S62}
======================================

Burns pose a highly complex problem in medical care. The high susceptibility to microbial infection coupled with the need to achieve rapid and satisfactory wound healing, while at the same time avoiding undesirable scarring taxes the resources of even specialized burns units. While topical application of antimicrobial agents has formed the bedrock of burns care, alternative approaches including immune-based antimicrobial molecules, therapeutic microorganisms, antimicrobial phototherapy (PTT, PDT, blue and green light or NIR based therapies), and different kinds of cell therapy have been explored. Nonetheless, antimicrobial resistance developing in a wide range of microorganisms has created vast problems for topical treatment of burned infections in recent years. Since antibiotic-resistant microorganisms are now the main threat to public health, new advanced approaches such as nanotechnology are being investigated that may be able to offer novel therapeutic strategies in the post-antibiotic era.

Up until the present the most important problem in burn wounds has been chronic infections caused by some microorganisms such as *P. aeruginosa*, that are especially serious in deep burns with large areas involved. This is due to the intrinsic and acquired resistance of bacteria to antibiotics resulting in high mortality in burn wound patients.

A wide range of sophisticated nanostructures are now being explored in burn wounds, which may be able to overcome the problem of infection, while at the same time stimulating skin regeneration. Hence, in this review we have focused on both organic and non-organic NSs including polymeric NPs, NEs, SLNs, hydrogels, ceramic NPs, metal NPs, TiO~2~ NPs, MNPs, carbon-based NPs, QDs and NFs all of which could be possibly utilized as potential antimicrobial agents in burns. In addition, other NS-based platforms may be more directed towards improving burn wound healing such as 3D-scaffolds, wound dressings and films, strategies to deliver growth factors, and stimuli-responsive NSs. These various platforms can be effectively utilized for wound therapy applications such as PDT, PTT, stimulus-sensitive drug delivery, cell therapy, growth factor delivery, and gene therapy.

NSs can be incorporated into dressings that are applied to the burned area, especially for inhibition of microbial proliferation, modulation of immune response, and acceleration of wound healing. Studies have shown that NSs either used alone or as multifunctional targeted and smart agents can be effective strategies to inhibit microbial growth in the burn wound microenvironment. NSs can also be implemented to design stem cell--based scaffolds for skin regeneration and remodeling. The unique properties of stem cells combined with nano-structured scaffolds may give rise to insights that may lead to substantial advancements in burn therapy. The advanced properties of NSs suggest they can be a technological step forward to prevent infections in thermal wounds and improved healing of damaged tissues compared with conventional topical treatments.

Burn wound healing can also be improved by using scaffolds possessing innovative features that have been fabricated via novel and user-friendly techniques. Materials such as electrospun NFs, smart stimuli-responsive and multifunctional 3D-scaffolds with favorable properties including the ability to control proliferation, migration and differentiation of various cell types, loading and on-demand release of antimicrobial therapeutics, and so forth, will lead to more effective wound therapies and suppression of burn infection. More importantly, recently developed technologies including 3D/4D-printing, use of cell-imprinted substrates, and nano-scale architectured surfaces have emerged with beneficial properties and features. In addition, some biotechnology-related advances such as powerful gene-editing techniques including CRISPR-Cas-based systems will create a milestone in the therapy of various diseases, particularly with major effects on treatment of (burn) wound healing and suppression of pathogens and infections, which are expected to become reality in the coming years.

Considering the immense research effort that is currently being invested in nanomedcine applications, future progress in burn treatment is expected to result from these above-mentioned innovative approaches.
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![Schematic illustration of important conventional, developing or innovative approaches, (such as light therapy; therapeutic microorganisms e.g. bacteriophages and bacteria with bactericidal effects; antibacterial NPs or NPs with therapeutic effects e.g. silver NPs and gold NPs; innovative nanocarriers e.g. smart nanocarriers and nanogels; novel scaffolds for wound dressing, (stem) cell therapy and regenerative medicine, therapeutic (drug, growth factor, gene, etc.) delivery, and so forth; and innovative technologies e.g. 3D-printing, cell-imprinting, and CRISPR-Cas9 gene editing), which have been the subject of various researches, conducted with the aim of wound healing and prevention of infection in burns.](nihms898183f1){#F1}

![Schematic illustration of: a) the structure of skin, b) layers of skin including epidermis, dermis and hypodermis, and their constituent cells and sub-layers.](nihms898183f2){#F2}

![Assessment of skin burn in terms of total body surface area (TBSA) percent, using the rule of nines in applied area, thus to quickly estimate the affected TBSA percent.](nihms898183f3){#F3}

![a) The platform based on GQDs/low level H~2~O~2~ used as antibacterial agent, b) The GQD equipped bandage for disinfection of the wound site in vivo Reprinted with permission from ref. \[[@R239]\], copyright 2014, American Chemical Society.](nihms898183f4){#F4}

![Curves showing morphological measurements evaluations from mice treated with SHAM group, GEL (hydrogel), GEL/ASCs at the burn wound site: a) wound size measurement; 1, 2, and 3 weeks after burn injury initiation compared to initial injury. Here, no effect of the gel wound dressing and wound closure was reported, b) and c) wound thickness (mm) after 1 and 2 week, and area occupied by nuclei, respectively, indicative of granulation tissue, which was facilitated by ASC-containing gels, c) Quantitative measurement of blood vessels in regenerating regions 1 week after the burn initiation. SHAM group (untreated), GEL group (treated only with P-fibrin gel), and GEL/ASCs group (GEL group integrated with adipose-derived stem cells) Reprinted with permission from ref. \[[@R267]\], copyright 2016, John Wiley & Sons, Inc.](nihms898183f5){#F5}

![Schematic of the synthesis procedure of QCSP/PEGS-FA hydrogels. Reprinted with permission from ref. \[[@R277]\], copyright 2017, Elsevier.](nihms898183f6){#F6}

![a) Schematic illustrating the fabrication process of the biocomposite wound dressing, b) microscopic images of 8mm full thickness wounds of C57BL/6J mice on day 21 after the burn injury initiation: (i) Spontaneous healing, (ii) OP-Gel, (iii) OP-Gel-NS, (iv) OP-Gel-Cipro, and (v) Bactigras, c) Histological analysis of the excised tissue at wound site: (i) intact tissue at first day, treated tissue after 3 weeks under different conditions of: (ii) Spontaneous healing, (iii) using OP-Gel, (iv) using OP-Gel- NS, (v) using OP-Gel-Cipro and (vi) using Bactigras (commercially available dressing). Reprinted with permission from ref. \[[@R278]\], copyright 2016, Elsevier.](nihms898183f7){#F7}

![a) Scanning electron microscopy of RADA16, (b) RADA16-FPG and (c) RADA16-RGD. (d) Cell viability result for the implemented keratinocyte (i.e. HaCaT) and fibroblast (i.e. NIH/3T3) using the three 1% w/v RADA16 NF scaffolds and cell control after 0 hour and 3 days of incubation. Reprinted from ref. \[[@R288]\], copyright 2014, Nature (licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License).](nihms898183f8){#F8}

![a) Fluorescence micrographs of cells showing clustered growth after days 3 on HEMA (left; scaffolds coated with fibronectin were seeded with NIH/3T3 mouse fibroblasts); with homogenous growth of the cells cultured on pH-sensitive DMAEMA/HEMA scaffolds (right) \[[@R299]\], b) percentage swelling of zinc ion containing hydrogels; c) TA release from the hydrogels, at various pH values Reprinted with permission from ref. \[[@R300]\], copyright 2016, American Chemical Society; d) Scheme illustrating the synthesis of enzyme-sensitive self-assembled polymeric vehicles (from PEG-b-PP and PEG-b-PC) for selective delivery of antibiotics. They were designed to be responsive to penicillin G amidase (side chain cleavage) and to β-lactamase (microstructural transformation). This stimulus-responsive nanoplatform resulted in the constant cargo liberation and bioactivity of the encapsulated antimicrobial agent Reprinted with permission from ref. \[[@R302]\], copyright 2015, John Wiley & Sons, Inc.](nihms898183f9){#F9}

![a) Images of the infected wounds with different treatments: (i, ii) Untreated wounds on control at postoperative day 0 and 7. (iii, iv) Infected untreated wounds on postoperative day 0 and 7. (v, vi) Infected wounds treated ultrasound-activated TiO~2~ (UIT) on postoperative day 0 and 7, b) Effect of ultrasound-activated TiO~2~ on the treatment of the infected wound in regard to wound size percentage according to the initial wound size (day 0) Reprinted with permission from ref. \[[@R304]\] copyright 2016, John Wiley & Sons, Inc., c) Scheme of the smart antimicrobial system. Here, the exposure to lysozyme led to hydrolysis of NAc-CTS to give COS. The generated COS served as a substrate for CDH that produces the antimicrobial H~2~O~2~. Reprinted with permission from ref. \[[@R305]\], copyright 2017, John Wiley & Sons, Inc.](nihms898183f10){#F10}

![a) Scheme of a PEG-MoS~2~ nanoplatform to destroy bacteria via a synergistic combination of peroxidase catalysis and photothermal activation: (i) Capture of the nanoplatform by bacteria; (ii) catalytic activity of the nanoplatform decomposes low-concentration H~2~O~2~, leading to generation of ·OH that damages cell wall integrity; 808 nm laser treatment induces hyperthermia, causing accelerated GSH oxidation, b) Relative bacterial viability for *B. subtilis*, obtained after incubation with PBS, MoS~2~ (100 µg mL^−1^), H~2~O~2~ (100 µM), or MoS~2~+H~2~O~2~ for 20 min, with or without the laser treatment, c) GSH loss after heating by water bath or 808 nm NIR-irradiation compared to control (non-treated GSH) for 20 min at 50 °C. Reprinted with permission from ref. \[[@R315]\], copyright 2016, American Chemical Society, d) Photomicrographs indicating PDT-triggered healing: (i) normal skin, (ii) wound without infection, (iii) infected wounds, (iv) infected wounds with 200 µM pl--cp6 treatment, and (v) infected wounds with 200 µM pl--cp6 treatment plus with exposure to the light dose of 60 J/cm^2^. Reprinted with permission from ref. \[[@R316]\], copyright 2013, Springer.](nihms898183f11){#F11}

![a) Scheme illustrating the preparation of hydrogel sheet loaded with hEGF, used for healing of full thickness wounds, b) Wound closure-time curve in mice; and c) Macroscopic images of wound sites, obtained for different samples compared to non-treated controls. Reprinted with permission from ref. \[[@R328]\], copyright 2016, Elsevier.](nihms898183f12){#F12}

![Schematic of 3D-printing technology developed for the fabrication of 3D-scaffolds and dressings, within which cell-matrix components can be implanted, with applications in burn wound healing and tissue regeneration.](nihms898183f13){#F13}

![Schematic representing the concept of using gene editing tools such as CRISPR-Cas for reprogramming of stem cells (e.g. iPSCs) in wound healing applications](nihms898183f14){#F14}

![I--II) In Stevens burn model, a deep burn wound is generated using two blocks of brass with pre-heating of 92--95°C on a shaved mouse back. III) Square show burned region. IV) Bacterial suspension in PBS was used on the surface of burn. Reprinted from ref. \[[@R391]\], copyright 2011, Taylor and Francis Group (open access, licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.)](nihms898183f15){#F15}

###### 

Cellular and molecular events in normal wound healing

  Phases                                                                                                                     
  -------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------
  **Homeostasis**                                                                                                            Platelet aggregation, immunity activation, blood clotting and complement system induction
  **Inflammination**                                                                                                         Recruitment of neutrophils and macrophages as well as ECM molecule production by resident cells in the skin
  **Proliferation**                                                                                                          *Re-epithelialization*; expansion of keratinocytes, epithelial cells, stem cells and fibroblasts
  *Angiogenesis*; activation of endothelial cells and creation of a site in which these cells can proliferate in the wound   
  *Granulation*; the promotion of tissue granulation by fibroblasts, granulocytes and macrophages                            
  **Remodeling**                                                                                                             Production of collagen and elastin as well as fibroblasts maturing to myofibroblasts in the presence of T cells and macrophages

###### 

Topical methods for prevention and treatment of burn infection and wound healing

  ---------------------------------------------------------------------
  Biological-based approaches for burn wounds healing:
  **- Immune-based antimicrobial molecules**
  Antimicrobial peptides (AMPs)
  Passive immunotherapy
  **- Reactive oxygen species and nitric oxide generators**
  \-
  **- Antimicrobial agents**
  Metallic elements
  Biopolymeric agents
  **- Therapeutic microorganisms**
  **Antimicrobial light and ultrasound-based wound therapy:**
  **Phototherapy**
  **Shockwave and ultrasound based-therapy**
  **Stem cell based-burn therapy**
  **Burn wound infection therapy using nanostructures (NSs) and NPs**
  ---------------------------------------------------------------------
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